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Abstract
Mood and anxiety disorders are common during pregnancy and the postpartum period. The goal of this
dissertation was to investigate factors specific to the perinatal period related to the development,
treatment, and prevention of depression and anxiety. In Chapter 1, we investigated the role of a risk factor
specific to the perinatal period: maternal attitudes. We developed a measure of this construct and used
this measure to assess the relationship between these attitudes and symptoms of depression and anxiety
among first-time pregnant and postpartum mothers. Dysfunctional maternal attitudes predicted
symptoms of depression and anxiety, and these attitudes had incremental predictive validity over general
cognitive biases and interpersonal risk factors. In Chapters 2 and 3, we conducted meta-analyses
assessing the efficacy of interventions for depression among perinatal populations and investigated
whether characteristics of study design and interventions were associated with systematic differences in
effect sizes. In Chapter 2, we included 27 studies assessing the efficacy of treatments for depression
during pregnancy and the first year postpartum. We found that interventions resulted in significant
reductions in depressive symptoms from pre-treatment to post-treatment, and symptom levels at posttreatment were below cutoff levels indicative of clinically significant symptoms. At post-treatment,
intervention groups demonstrated significantly greater reductions in depressive symptoms compared to
control groups. In Chapter 3, we included 37 studies assessing the efficacy of preventive interventions for
postpartum depression. We found that depressive symptoms at six months postpartum were significantly
lower in intervention conditions as compared to control conditions, and there was a significant reduction
in the prevalence of depressive episodes in treatment conditions compared to control conditions. These
studies further our understanding of the processes that place women at risk for emotional distress in the
context of pregnancy and the postpartum period and suggest that a wide range of interventions are
effective for treating and preventing depression in this population.
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ABSTRACT
THE DEVELOPMENT, TREATMENT, AND PREVENTION OF PERINATAL MOOD
AND ANXIETY DISORDERS
Laura E. Sockol
Jacques P. Barber
Mood and anxiety disorders are common during pregnancy and the postpartum period.
The goal of this dissertation was to investigate factors specific to the perinatal period
related to the development, treatment, and prevention of depression and anxiety. In
Chapter 1, we investigated the role of a risk factor specific to the perinatal period:
maternal attitudes. We developed a measure of this construct and used this measure to
assess the relationship between these attitudes and symptoms of depression and anxiety
among first-time pregnant and postpartum mothers. Dysfunctional maternal attitudes
predicted symptoms of depression and anxiety, and these attitudes had incremental
predictive validity over general cognitive biases and interpersonal risk factors. In
Chapters 2 and 3, we conducted meta-analyses assessing the efficacy of interventions for
depression among perinatal populations and investigated whether characteristics of study
design and interventions were associated with systematic differences in effect sizes. In
Chapter 2, we included 27 studies assessing the efficacy of treatments for depression
during pregnancy and the first year postpartum. We found that interventions resulted in
significant reductions in depressive symptoms from pre-treatment to post-treatment, and
symptom levels at post-treatment were below cutoff levels indicative of clinically
significant symptoms. At post-treatment, intervention groups demonstrated significantly
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greater reductions in depressive symptoms compared to control groups. In Chapter 3, we
included 37 studies assessing the efficacy of preventive interventions for postpartum
depression. We found that depressive symptoms at six months postpartum were
significantly lower in intervention conditions as compared to control conditions, and
there was a significant reduction in the prevalence of depressive episodes in treatment
conditions compared to control conditions. These studies further our understanding of the
processes that place women at risk for emotional distress in the context of pregnancy and
the postpartum period and suggest that a wide range of interventions are effective for
treating and preventing depression in this population.
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General Introduction

2
Perinatal depression and anxiety are common psychological disorders with
important public health implications. Approximately 10-15% of women experience a
depressive episode during pregnancy or the first year postpartum (Bennett, Einarson,
Taddio, Koren & Einarson, 2004; Joseffson, Berg, Nordin & Sydsjo, 2001). Anxiety
disorders are also common during pregnancy (Lee, Lam, Lau, Cong, Chui, & Fong,
2007) and the first year postpartum (Stuart, Couser, Schilder, O’Hara, & Gorman, 1998;
Wenzel, Haugen, Jackson, & Brendle, 2005). While clinicians previously believed that
pregnancy was protective against mental illness, we now know that the risk of mental
illness is at least comparable between childbearing and non-childbearing women
(O’Hara, Zekoski, Philipps, & Wright, 1990), and there is some evidence that women are
at increased risk for psychopathology during the perinatal period (Eberhard-Gran, Eskild,
Tambs, Samuelsen, & Opjordsmoen, 2002; Eberhard-Gran, Tambs, Opjordsmoen,
Skrondal, & Eskild, 2003).
The context in which women with perinatal depression and anxiety experience
their symptoms is important to consider in order to fully understand these disorders. The
distress experienced by women with these disorders is often exacerbated by feelings of
guilt and isolation that accompany women’s perceptions that their experiences deviate
from cultural norms and expectations (Mauthner, 1999). Clinicians may not identify
women experiencing these disorders due to beliefs that pregnancy is protective against
mental illness (Cohen et al., 2006). Difficulty distinguishing between normal responses to
the stresses of pregnancy and parenting, the “baby blues,” and psychopathology can also
result in a failure by women and their physicians to identify psychological disorders
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during this time. Even when women at-risk for psychological difficulties are identified
during pregnancy and the early postpartum period, the majority do not receive treatment
for their symptoms (Horowitz & Cousins, 2006).
In addition to the distress experienced by women who experience perinatal
depression and anxiety, these disorders confer additional risk on the developing fetus and
child. Depression during pregnancy is associated with increased risk for preterm birth,
low birth weight, intrauterine growth restriction, and preeclampsia (Grote, Bridge, Gavin,
Melville, Iyengar, & Katon, 2010; Kim, Sockol, Sammel, Kelly, Moseley, & Epperson,
2012). Prenatal anxiety is also associated with poor birth outcomes (Littleton, Breitkopf,
& Berenson, 2007). Children of depressed and anxious mothers are at increased risk for a
wide range of problems. Maternal depression during the first year postpartum is
associated with long-term behavioral problems, emotional difficulties, and impaired
cognitive development, particularly among boys and children of low socioeconomic
status (Grace, Evindar, & Stewart, 2003). Maternal anxiety is also associated with
increased risk for behavioral and emotional difficulties (O’Conner, Heron, Glover, & the
ALSPAC Study Team, 2002).
Identification of risk factors for perinatal depression and anxiety can help guide
researchers and clinicians in identifying women at-risk for these disorders and suggest
potential targets for intervention and prevention. Epidemiological research has identified
many risk factors for these disorders. A personal or familial history of depression or an
anxiety disorder is among the strongest predictors that a woman will experience
depression or anxiety during pregnancy or the first year postpartum (C. Beck, 2001;
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O’Hara & Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). Women who
are members of racial/ethnic minorities, single women, and women of low
socioeconomic status are at increased risk for depression and anxiety (C. Beck, 2001;
Littleton, Breitkopf, & Berenson, 2007; O’Hara & Swain, 1996; Robertson, Grace,
Wallington, & Stewart, 2004). Interpersonal stressors, including a lack of social support
and low marital satisfaction, are also associated with increased risk (C. Beck, 2001;
O’Hara & Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). Psychological
characteristics associated with increased risk for these disorders include perfectionism
and a negative attributional style (C. Beck, 2001; O’Hara & Swain, 1996; Robertson,
Grace, Wallington, & Stewart, 2004).
While these risk factors can help clinicians and researchers identify women at-risk
for distress during the transition to parenthood, it is important to note that many of these
risk factors are challenging targets for intervention. An important goal for research in this
area is the identification of risk factors that can serve as targets for prevention and
intervention. Beck’s cognitive model provides an approach to conceptualizing these
disorders that suggests risk factors that may be amenable to intervention. According to
this model, the relationship between an individual’s experience and his emotional
response is mediated by cognitive processes (A. Beck, 1967; 1976; 1985). Maladaptive
emotional responses, such as depression and anxiety, result from systematic biases in
cognition. Importantly, these biases can be targeted through psychological interventions,
particularly cognitive-behavioral therapies (Appleby, Warner, Whitton, & Faragher,
1997; Cooper, Murray, Wilson, & Romaniuk, 2003).
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It is also important for research to identify risk factors that may be specific to
perinatal psychopathology. There is evidence that a subset of women who are particularly
vulnerable to depression and anxiety during the perinatal period are not otherwise at risk
for these disorders (Bloch, Schmidt, Danaceau, Murphy, Nieman, & Rubinow, 2000;
Cooper & Murray, 1995). Beliefs and attitudes related to motherhood may function as a
specific cognitive vulnerability to depression and anxiety in the context of pregnancy and
the transition to parenthood. There is evidence that maternal attitudes are associated with
poor psychological adjustment for pregnant and postpartum women (Sockol, 2008;
Warner, Appleby, Whitton, & Faragher, 1997). However, research in this area has been
limited by conceptual and psychometric problems with measures commonly used to
assess maternal attitudes (Sockol, 2008).
Identification of women at risk for perinatal depression and anxiety may help
clinicians and researchers identify women who would benefit from preventive
interventions. Research has investigated the efficacy of a wide range of interventions to
reduce the prevalence of psychopathology during the perinatal period. The perinatal
period may be a particularly opportune time to initiate preventive interventions, as
pregnancy and the early postpartum period are times of increased healthcare utilization
and access.
While research suggests that the prevalence of depression and anxiety can be
reduced through preventive interventions, high-risk individuals who receive these
interventions often develop psychological disorders (Cuijpers, van Straten, Andersson, &
Van Oppen, 2008; Zalta, 2011). Given the prevalence and consequences of these
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disorders, the identification of effective treatments has important public health
implications. Concerns unique to the perinatal period may influence the efficacy of
treatments for perinatal women (Kim, O’Reardon, & Epperson, 2010). Due to concerns
about fetal exposure to antidepressants, concerns about breastfeeding, and the need for
higher doses of medication during pregnancy, medications may be prescribed below
therapeutic levels (Bennett, Einarson, Taddio, Koren, & Einarson, 2004; Dawes &
Chowienczyk, 2001; Epperson, Anderson, & McDougle, 1997; Epperson, Jatlow,
Czarkowski, & Anderson, 2003; Hostetter, Stowe, & Strader, 2000; Wisner, Perel, &
Wheeler, 1993). Biological and psychosocial changes that occur in the context of
pregnancy and parenting, including sleep deprivation, disruptions to the hormonal milieu,
alterations to HPA axis functioning, and changes to interpersonal relationships, introduce
challenges that may affect the efficacy of both pharmacological and psychotherapeutic
interventions (Dennis & Ross, 2005; Kammerer, Taylor, & Glover, 2006). There are also
concerns related to the acceptability of interventions for perinatal psychopathology: the
majority of women indicate a preference for psychological interventions to medication
during both pregnancy and the postpartum period, and the overall acceptability of
pharmacotherapy among these groups is low (Chabrol, Teissedre, Armitage, Danel &
Walburg, 2004; Kim et al., 2011). Thus the identification of efficacious interventions,
particularly psychological interventions, for this population is an important and growing
area of research.
The goals of the studies included in this dissertation are to further our
understanding of the development, treatment, and prevention of mental illness during
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pregnancy and the first year postpartum. In Chapter 1, we developed a measure for
assessing maternal attitudes, a potential risk factor for perinatal depression and anxiety.
We then used this measure to assess the predictive validity of maternal attitudes in
relation to symptoms of depression and anxiety among first-time mothers, and to
investigate the relationship between maternal attitudes and other known risk factors for
these disorders. In Chapter 2, we conducted a quantitative review of the literature on the
treatment of depression during pregnancy and the first year postpartum. We used metaanalysis to assess the overall effectiveness of interventions for perinatal depression by
assessing changes in depressive symptoms over time and the differences between
treatment and control conditions in randomized and quasi-randomized trials of
interventions for these disorders. We also assessed whether characteristics of studies and
interventions were associated with systematic differences in effect sizes. Finally, in
Chapter 3, we conducted a quantitative review of the literature on the prevention of
postpartum depression. We used meta-analysis to assess whether preventive interventions
are associated with decreased levels of depressive symptoms and reduced incidence of
depressive episodes during the first six months postpartum. As in Chapter 2, we also
assessed whether characteristics of studies and interventions were associated with
systematic differences in effect sizes. Overall, these studies further our understanding of
the mechanisms by which perinatal depression and anxiety disorders develop and the
most effective ways to treat and prevent them.
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Chapter 1:
The Relationship Between Maternal Attitudes and Symptoms of Depression and Anxiety
Among Pregnant and Postpartum First-Time Mothers

15
Abstract
Two studies examined the role of attitudes toward motherhood in relation to symptoms of
depression and anxiety among first-time mothers during pregnancy and the early
postpartum period. In the first study, a measure of maternal attitudes, the Attitudes
Toward Motherhood Scale (AToM) was developed and validated in a sample of first-time
mothers. The AToM was found to have good internal reliability and convergent validity
with general cognitive biases and an existing measure of maternal attitudes. Exploratory
and confirmatory factor analyses determined that the measure comprises three correlated
factors representing beliefs about others’ judgments, beliefs about maternal
responsibility, and maternal role idealization. In the second study, we used the AToM to
assess the relationship between maternal attitudes and other psychological variables
among pregnant and postpartum first-time mothers. The factor structure of the measure
was confirmed and found to be invariant across pregnant and postpartum subjects.
Dysfunctional maternal attitudes predicted symptoms of depression and anxiety, and
these attitudes had incremental predictive validity over general cognitive biases and
interpersonal risk factors. Dysfunctional maternal attitudes were related to neuroticism
but not to other personality factors. Overall, the results of these studies suggest that
attitudes toward motherhood are related to psychological distress among first-time
mothers during the transition to parenthood and may provide a useful means of
identifying women who may benefit from intervention during pregnancy and the early
postpartum period.
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The Relationship Between Maternal Attitudes and Symptoms of Depression and Anxiety
Among Pregnant and Postpartum First-Time Mothers
Emotional distress during the perinatal period is one of the most common
complications of childbearing. Approximately 10-15% of women experience a depressive
episode during pregnancy or the first year postpartum (Bennett, Einarson, Taddio, Koren
& Einarson, 2004; Joseffson, Berg, Nordin & Sydsjo, 2001). High levels of anxiety are
also common during pregnancy (Lee, Lam, Lau, Cong, Chui, & Fong, 2007) and the first
year postpartum (Stuart, Couser, Schilder, O’Hara, & Gorman, 1998; Wenzel, Haugen,
Jackson, & Brendle, 2005).
Depression and anxiety during the perinatal period are associated with adverse
fetal and child outcomes. Depression during pregnancy is associated with increased risk
for preterm birth, low birth weight, and preeclampsia (Grote, Bridge, Gavin, Melville,
Iyengar, & Katon, 2010; Kim, Sockol, Sammel, Kelly, Moseley, & Epperson, 2012).
Postpartum depression is a risk factor for a range of adverse child outcomes, including
behavioral problems and impaired cognitive development (Grace, Evindar, & Stewart,
2003). Prenatal anxiety is also associated with poor birth outcomes (Littleton, Breitkopf,
& Berenson, 2007), and maternal anxiety is a risk factor for behavioral and emotional
maladjustment in children, even controlling for the effects of depressive symptoms
(O’Conner, Heron, Glover, & the ALSPAC Study Team, 2002). Given the prevalence
and potential consequences of perinatal depression and anxiety, research that helps
clinicians and researchers effectively identify women at-risk for these disorders and
develop effective interventions is vitally necessary.
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Epidemiological research has identified a wide range of risk factors for perinatal
depression and anxiety. A personal or familial history of major depressive episodes is
among the most potent predictors of perinatal depressive symptoms (Beck, 2001; O’Hara
& Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). Women of low
socioeconomic status, ethnic/racial minorities, and single women are also at higher risk
for perinatal depression and anxiety (Beck, 2001; Littleton, Breitkopf, & Berenson, 2007;
O’Hara & Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). While these
risk factors can help clinicians and researchers identify women at-risk for distress during
the transition to parenthood, many of these risk factors are challenging to modify. An
important goal for research in this area is the identification of risk factors that can serve
as targets for prevention and intervention.
Beck’s cognitive model provides a conceptual framework that may guide us in the
identification of vulnerability factors for depression and anxiety that could be targeted for
intervention. According to this model, cognitive biases confer a vulnerability to
symptoms of depression and anxiety in the context of potentially stressful life events
(Beck, 1967; 1976; 1985). According to this model, the relationship between life events
and emotional experiences is mediated by cognitive processes. Maladaptive emotional
responses, such as depression and anxiety, result from biases in these cognitive processes.
In depressed individuals, these biases are commonly characterized by a negative view of
the self, world, and future (Beck, 1967; 1976). Among individuals with anxiety disorders,
cognitions are frequently characterized by heightened perceptions of threat and danger
(Beck, 1985). Previous research has demonstrated that negative cognitive biases are
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associated with depression during pregnancy and the postpartum (Cutrona, 1983; Grazioli
& Terry, 2000; Hull & Mendolia, 1991; O’Hara, Rehm, & Campbell, 1982). While this
construct has received relatively less attention in relation to perinatal anxiety, cognitive
biases are also associated with symptoms of anxiety among this population (Littleton,
Breitkopf, & Berenson, 2007). Importantly, these biases can be targeted through
psychological interventions, particularly cognitive-behavioral therapies (Appleby,
Warner, Whitton, & Faragher, 1997; Cooper, Murray, Wilson, & Romaniuk, 2003).
While much research on cognitive vulnerability to depression and anxiety has
focused on general negative biases, there is also evidence that specific types of cognitions
may interact with particular stressors to produce maladaptive emotional responses.
According to this “event congruency hypothesis,” an individual’s characteristic cognitive
style may leave them differentially vulnerable to distress in the context of negative events
that are congruent with the important components of their maladaptive schemas (FrancisRaniere, Alloy, & Abramson, 2006; Segal, Shaw, Vella, & Katz, 1992). Most research in
this area has investigated the role of self-criticism and dependency, two particular styles
of negative cognition, in interaction with life events that are achievement- or
interpersonally-oriented. Overall, the results of longitudinal research in this area suggest
that individuals who have a self-critical cognitive style are particularly vulnerable to
depressive episodes following achievement-oriented stressors, while individuals with a
dependent cognitive style are particularly vulnerable to depressive episodes following
interpersonally-oriented stressors (Hammen, Marks, Mayos, & deMayo, 1985; Hammen,
Ellicott, Gitlin, & Jamison, 1989; Francis-Raniere, Alloy, & Abramson, 2006).
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Interestingly, research among perinatal populations suggests that self-criticism is a risk
factor for depressive symptoms, while dependency is not associated with increased risk
for depression (Besser & Priel, 2003; Besser, Priel, Flett, & Wiznitzer, 2007).
There is also evidence that the specific content of maladaptive cognitions may
confer risk for psychopathology in the context of relevant stressors. For example,
Schmidt, Lerew, and Jackson (1997) studied whether anxiety sensitivity, a hypothesized
cognitive risk factor for panic disorder, predicted the occurrence of panic attacks among
young adults enrolled in a five-week basic training program at the Air Force Academy.
They found that anxiety sensitivity predicted the probability that recruits would
experience a panic attack during this period, even controlling for a history of previous
panic attacks. Hillman and Garber (1995) found that cognitions related to academic
competence and academic self-control predicted negative affect and depressive
symptoms among elementary-school children whose grades were lower than expected.
Beliefs specifically related to academic competence and self-control had incremental
predictive validity beyond the students’ general attributional style. These studies suggest
that it may be possible to identify specific maladaptive beliefs that are conceptually
related to potential stressors that place an individual at-risk for negative emotional
responses.
With regard to perinatal depression and anxiety, beliefs and attitudes about
motherhood have the potential to function as a specific cognitive vulnerability. While
cognitive biases are a general risk factor for depression and anxiety, attitudes toward
motherhood may also mediate the relationship between the specific stressors women
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experience during pregnancy and early parenthood and their emotional responses to these
events. As such, maternal attitudes would represent an additional and more specific risk
factor for symptoms of depression and anxiety among perinatal populations.
There is evidence supporting an association between negative attitudes towards
motherhood and depression during pregnancy and the first year postpartum. Women’s
expectations of motherhood and attitudes toward role conflict predict subsequent
depressive symptoms during pregnancy (Warner, Appleby, Whitton, & Faragher, 1997).
Women’s attitudes toward performance-oriented elements of motherhood are predictive
of later depressive symptoms (Grazioli & Terry, 2000). Women’s attitudes towards
motherhood have also been found to mediate the relationship between parental stress and
depressive symptoms (Church, Brechman-Toussaint, & Hine, 2005). Dysfunctional
maternal attitudes predict concurrent levels of depressive symptoms during pregnancy
and the early postpartum period, and changes in maternal attitudes from pregnancy
through six weeks postpartum predict depressive symptoms at six weeks postpartum,
even controlling for prior depressive symptoms (Sockol, 2008).
While maternal attitudes appear promising as a means of identifying women atrisk for perinatal depression and anxiety and as a target for intervention, research in this
area has been limited by the lack of an adequate measure of this construct. Several
measures designed for use by women during pregnancy emphasize women’s expectations
of parenthood (Belsky, 1985; Harwood, 2004; Kalmuss, Davidson, & Cushman, 1992).
However, given that pregnancy and parenthood are inherently periods of increased stress,
negative expectations may not only be accurate, but may serve a protective function.
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Women tend to have overly negative expectations of parenthood, but these negative
expectations do not predict psychological maladjustment – rather, women whose actual
experiences are more negative than their expectations are at increased risk for postpartum
depressive symptoms (Harwood, 2004). Other measures of maternal attitudes likewise
confound attitudes toward motherhood with women’s experiences of pregnancy and
parenting (DiPietro, Ghera, Costigan, & Hawkins, 2004; Kumar, Robson, & Smith, 1984;
Warner, Appleby, Whitton, & Faragher, 1997). The cognitive models of depression and
anxiety emphasize the role of individuals’ beliefs in the interpretation of the events they
experience, thus it is important that assessments of cognitive biases are careful to
distinguish between appraisals of life events and the events themselves.
In addition to conceptual limitations of existing measures of maternal attitudes,
our previous research has identified psychometric problems with a commonly used
measure of this construct. Specifically, in a previous study of the role of maternal
attitudes in predicting perinatal depressive symptoms, we found that the Maternal
Attitudes Questionnaire (Warner, Appleby, Whitton, & Faragher, 1997) had poor internal
reliability, particularly among subjects who were pregnant with their first child (Sockol,
2008). Examination of the content of the measure reveals items, such as “Having a baby
has made me as happy as I expected,” that may be confusing or inappropriate for
primiparous pregnant women. Given these limitations, the development of a valid and
reliable measure of maternal attitudes is necessary for further research assessing their role
as a potential risk factor for perinatal depression and anxiety.
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The overarching goal of the present research was to develop a measure of
maternal attitudes appropriate for use with first-time mothers, both pregnant and
postpartum, and to use this measure to assess the relationship between maternal attitudes
and emotional distress. We hypothesized that dysfunctional maternal attitudes would
predict symptoms of depression and anxiety and have incremental predictive validity
over and beyond general cognitive biases and interpersonal risk factors.
Study 1
The goal of Study 1 was to validate a self-report measure of maternal attitudes in
a sample of first-time mothers. We conducted exploratory and confirmatory factor
analyses to assess the psychometric properties of the measure. We expected that attitudes
toward motherhood would comprise several factors reflecting specific types of beliefs
related to motherhood. We tested the convergent validity of the Attitudes Toward
Motherhood Scale (AToM) with a measure of general cognitive biases (the Dysfunctional
Attitudes Scale, DAS; Weissman & Beck, 1978) and an existing but flawed measure of
maternal attitudes (the Maternal Attitudes Questionnaire, MAQ; Warner, Appleby,
Whitton, & Faragher, 1997). We expected that maternal attitudes as measured by the
AToM and MAQ would correlate strongly with one another and that participants’ scores
on the AToM would also be strongly related to general cognitive biases. Furthermore, we
expected the AToM to have superior reliability to the MAQ, particularly among pregnant
participants.
Method
Participants and procedures.
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Participants for this study were recruited online via social media through sites
such as Facebook, Twitter, and online forums for women who are pregnant or parenting
(e.g., CafeMom). Specifically, an invitation to participate in a “study of the way women
think about motherhood” and a link to an online survey was posted on these sites in the
spring of 2011. The survey site included an online consent form followed by eligibility
questions, a series of self-report questionnaires and, finally, questions about demographic
variables. Participants were compensated via a raffle for $150.
Two hundred thirty-four women initiated participation in the study. Women were
eligible to participate if they were between the ages of 18 and 45, resided in the United
States, and were either pregnant with their first child (between 13 and 40 weeks
gestational age) or had given birth to their first child within the previous 6 months. Three
subjects were excluded because they were under age 18, 14 subjects were excluded
because they were not pregnant or within six months of giving birth to their first child,
and 7 subjects were excluded because they did not reside in the United States. Of the 210
women who were eligible to participate, 65% (n = 136) women completed at least one
measure and 50% (n = 104) completed all study measures. We compared women who
dropped out at each stage of the study to women who completed the measures; there were
no differences between dropouts and completers on any measure.
Demographic characteristics of the sample are presented in Table 1. About 59%
of subjects were currently pregnant with their first child (n = 80) and 41% (n = 56) had
given birth to their child within the past 6 months. For pregnant subjects, the mean
gestational age was 26.1 weeks (SD = 8.3 weeks, range 13-40 weeks). The mean age of
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postpartum subjects’ children was 12.5 weeks (SD = 8.2 weeks, range 1-24 weeks). The
sample was predominantly married (65%) and Caucasian (78%) and represented a wide
range of socioeconomic backgrounds.
Measures.
Development of the Attitudes Toward Motherhood Scale. We began by
generating a pool of 62 items reflecting attitudes toward motherhood. Some items were
derived by modifying measures of general cognitive biases to reflect content specific to
motherhood (e.g., “Making mistakes caring for my baby is fine because I can learn from
them” was modified from the DAS item “Making mistakes is fine because I can learn
from them,” Weissman & Beck, 1978). We also modified items from a measure of
women’s expectations of motherhood to reflect beliefs, rather than expectations (e.g., “I
should not have difficulty becoming comfortable caring for my baby” was modified from
the Parenting Expectations Measure item “I will not have difficulty becoming
comfortable caring for my baby,” Harwood, 2004). Additional items were derived from a
manual of cognitive-behavioral therapy for postpartum depression which listed common
maladaptive beliefs expressed by these women (e.g., “Now that I am a mother, my past
lifestyle and activities should not be important,” Olioff, 1991) and from interviews with
women who were pregnant or mothers of children under the age of two years (e.g., “I feel
guilty about wanting to do the things I did before I became pregnant”). The set of items
proposed for inclusion in the measure was reviewed by a small group of graduate
students in clinical psychology who are familiar with the cognitive models of depression
and anxiety disorders. Their comments regarding item clarity and wording and additional

25
suggested items were used to modify the item pool. Finally, the measure was piloted
online with a small group of women recruited separately from those in the present study.
These women were asked to provide qualitative feedback after completing the measure;
these responses were used to refine the measure and to generate additional items.
Dysfunctional Attitudes Scale. General cognitive biases were assessed with the
short form of the Dysfunctional Attitude Scale (DAS), a 40-question self-report measure
designed to assess the various assumptions and beliefs posited by Beck (1967, 1976) to
underlie psychological maladjustment (Weissman & Beck, 1978). Subjects were asked to
rate, on a 7-point Likert scale, the degree to which they agree with statements of beliefs or
attitudes (e.g., “If I do not do well all the time, people will not respect me”). Higher scores
reflect more maladaptive cognitions. Cronbach’s alpha in the sample was 0.91 and was
comparable for the pregnant (α = 0.90) and postpartum (α = 0.90) samples.
Maternal Attitudes Questionnaire. Participants also completed an existing measure
of maternal attitudes, the Maternal Attitudes Questionnaire (MAQ; Warner et al., 1997).
This is a 14-question self-report measure that assesses cognitions in three domains:
expectations of motherhood, expectations of the self as a mother, and role conflict (e.g., “I
think my baby is very demanding”). Higher scores are indicative of more maladaptive
cognitions. As in our previous research, internal reliability for the measure was low (α =
0.63), especially among pregnant participants (α = 0.57, postpartum sample α = 0.64).
Results and Discussion
Of the original 62 items considered for inclusion in the AToM, we initially
retained 50% of items representing items with the greatest variance. We then conducted
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an exploratory factor analysis on the remaining 31 items. We used several means of
assessing the optimal number of factors: Cattell’s (1966) scree test, Bartlett’s chi-square
test (Geweke & Singleton, 1980), parallel analysis (Horn, 1965), and the minimum
average partial criterion (Velicer, 1976). These tests all suggested the optimal factor
solution would contain 2-4 factors, with a modal solution of 3 factors. We assessed the 2, 3-, and 4-factor structures for conceptual clarity of extracted factors and the best
approximation of simple structure. A three-factor structure with promax rotation satisfied
these criteria. An oblique factor rotation was used because the factors were assumed to
correlate with one another. Factor analysis was also conducted using an orthogonal
(varimax) rotation; the three-factor structure was replicated with this rotation (results not
shown).
The initial factor solution produced a 3-factor structure with 6-8 items loading on
each factor, for a total of 21 items. Each of these factors was then examined for
redundancy and item clarity. To reduce subject burden, we eliminated items with the
lowest factor loadings. Items with factor loadings < 0.60 were eliminated. See Table 2 for
the 12 retained items. The first factor contains four items that reflect beliefs related to
others’ judgments, the second factor contains four items reflecting beliefs related to
maternal responsibility, and the third factor contains four items reflecting beliefs related
to maternal role idealization. Cronbach’s alpha in the full sample was 0.81 and was
comparable for the pregnant (α = 0.82) and postpartum (α = 0.79) samples.
To test the integrity of the final three-factor solution, we used confirmatory factor
analysis to assess the overall fit of the three-factor model and to compare the three-factor
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model to a one-factor model. The three-factor model demonstrated good fit to the data ,
χ2(51) = 83.3, p < 0.01, SRMR = 0.08, CFI = 0.95, RMSEA = 0.07, p > 0.05. Comparison
of the three-factor solution to a one-factor solution indicated that the three-factor solution
was a significantly better fit to the data, χ2(3) = 233.81, p < 0.001.
Descriptive statistics for the study measures and intercorrelations among the
measures are presented in Table 3. We assessed the convergent validity of the AToM
using the DAS and MAQ. Due to the low reliability of the MAQ, we corrected the
correlations among the measures for attenuation according to Block’s (1963) method.
The AToM was significantly correlated with both general cognitive biases (r = 0.50 after
correction for attenuation) and maternal attitudes as assessed by the MAQ (r = 0.43 after
correction for attenuation), with magnitudes in the medium range. The MAQ was also
significantly correlated with general cognitive biases (r = 0.34 after correction for
attenuation). Meng, Rosenthal, and Rubin’s (1992) approach for comparing the
magnitude of correlation coefficients was used to assess the difference between these
correlations; there were no significant differences in the magnitude of the strength of the
relationships among the three variables.
We assessed the convergent validity of the three subscales of the AToM using the
same approach. Factor 1 of the AToM, comprising beliefs related to others’ judgments,
was moderately associated with Factor 3 of the AToM (comprising beliefs related to
maternal role idealization) and with the MAQ, and was strongly associated with general
cognitive biases. Factor 2 of the AToM, comprising beliefs related to maternal
responsibility, was not associated with Factor 1 of the AToM, general cognitive biases, or
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the MAQ, but was strongly associated with Factor 3 of the AToM. Factor 3 of the AToM,
comprising beliefs related to maternal role idealization, was moderately associated with
Factor 1 of the AToM, general cognitive biases, and the MAQ, and was strongly
associated with Factor 2 of the AToM.
Results of these analyses support our hypothesis that dysfunctional maternal
attitudes, as assessed using the AToM, are associated with general cognitive biases. We
also demonstrated that our measure has good convergent validity with an existing, but
problematic, measure of maternal attitudes. We did not find that dysfunctional maternal
attitudes, as assessed by the AToM and MAQ, were related more strongly to one another
than to general cognitive biases.
The pattern of correlations observed among the subscales of the AToM and the
MAQ and DAS suggest that beliefs related to maternal responsibility represent a distinct
facet of attitudes toward motherhood that, while related to maternal role idealization, are
distinct from general patterns of negative cognitive biases and other elements of maternal
attitudes. Beliefs related to others’ judgments appear most strongly related to general
cognitive biases, while beliefs related to maternal role idealization are only moderately
related to these general cognitive biases. The patterns of correlations observed among the
subscales of the measure suggest that, while the maternal attitudes assessed by the AToM
are related to general cognitive biases, they represent a separate construct.
Study 2
The goal of Study 2 was to use the AToM to assess the relationship between
maternal attitudes and psychological variables among first-time mothers during the
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transition to parenthood. We hypothesized that dysfunctional maternal attitudes would
predict symptoms of depression and anxiety among pregnant and postpartum first-time
mothers and that these attitudes would have incremental predictive validity over general
cognitive biases and interpersonal risk factors for depression and anxiety. We also
assessed the discriminant validity of the measure by assessing the relationship between
maternal attitudes and a broad range of psychological symptoms, as assessed by the Brief
Symptom Inventory (Derogatis & Spencer, 1982), and personality factors, as assessed by
the Big Five Inventory (John, Naumann, & Soto, 2008). We predicted that dysfunctional
maternal attitudes would be most strongly related to psychological symptoms that are
closely related to depression and anxiety (e.g., obsessiveness) and less strongly related to
other psychological symptoms (e.g., psychoticism and paranoia). We predicted that
dysfunctional maternal attitudes would be strongly related to neuroticism, but would be
less strongly associated with other personality factors.
Method
Participants and procedures.
Participants for this study were recruited in the spring of 2012 through the same
social media sites as for Study 1. The survey site included an online consent form
followed by eligibility questions, a series of self-report questionnaires and, finally,
questions about demographic variables. Participants were compensated by a raffle for
$150.
Three hundred and eighty-three women initiated participation in the study.
Women were eligible to participate if they were between the ages of 18 and 45, resided in
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the United States, and were either pregnant with their first child (between 13 and 40
weeks gestational age) or had given birth to their first child within the previous 6 months.
Four subjects were excluded because they were under age 18 or over age 45, 29 subjects
were excluded because they were not pregnant or within six months of giving birth to
their first child, and 11 subjects were excluded because they did not reside in the United
States. Of the 339 women who were eligible to participate, 85% (n = 288) completed at
least one measure and 62% (n = 211) completed all study measures. We compared
subjects who completed each measure to subjects who dropped out at each stage of the
study. Subjects who dropped out prior to completing the DAS had significantly higher
AToM scores than subjects who completed the DAS; subjects who dropped out prior to
completing the DYAD had significantly higher AToM and STAI scores than those who
completed the DYAD, and subjects who dropped out prior to completing the MDPSS had
significantly higher AToM and DYAD scores than those who completed the MDPSS.
Overall, the results of these analyses suggest that subjects at higher risk for psychological
difficulties were more likely to drop out of the study prior to completion of all measures.
Demographic characteristics of the sample are presented in Table 1. About 43%
of subjects were currently pregnant with their first child (n = 145), and 57% (n = 195)
had given birth to their child within the previous 6 month period. For pregnant subjects,
the mean gestational age was 24.1 weeks (SD = 7.2 weeks, range 12-39 weeks). The
mean age of postpartum subjects’ children was 13.9 weeks (SD = 7.0 weeks, range 1-24
weeks). The sample was predominantly married (79.5%) and Caucasian (94%). The
sample was highly educated and relatively affluent: 44.5% of subjects had a
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graduate/professional degree, 29.8% of subjects reported annual household incomes
greater than $100,000, and 51.6% of subjects reported that they were employed full-time.
Measures.
Cognitive risk factors. Attitudes toward motherhood were assessed using the
Attitudes Towards Motherhood Scale (AToM), described in Study 1. Cronbach’s alpha
for the scale was 0.86. General cognitive biases were assessed using the Dysfunctional
Attitudes Scale (DAS); to reduce subject burden we utilized the 17-item version (de
Graaf, Roelofs, & Huibers, 2009). Cronbach’s alpha for the scale was 0.92.
Interpersonal risk factors. Subjects who were married or in a committed
relationship completed the Dyadic Adjustment Scale (DYAD; Spanier, 1976), a 32-item
measure of relationship satisfaction. Cronbach’s alpha for the scale was 0.93. All subjects
completed the Multidimensionalal Scale of Perceived Social Support (MDPSS; Zimet,
Dahlem, Zimet, & Farley, 1988), which assesses satisfaction with perceived social support
from partners, family, and friends. Cronbach’s alpha for the scale was 0.94. As subjects’
scores on the MDPSS were non-normally distributed, the variable was square-root
transformed prior to analyses.
Psychological symptoms. Depressive symptoms were assessed using the Edinburgh
Post-Natal Depression Scale (EPDS; Cox, Holden, & Sagovsky, 1987). This 10-item
measure was developed for use by pregnant and postpartum women; the scale takes into
account normative experiences of perinatal women that correspond with diagnostic criteria
for depression (e.g., weight change and fatigue) that can bias other measures of depressive
symptoms. Scores greater than or equal to 12 are indicative of a possible depressive episode
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(Cox et al., 1996). Cronbach’s alpha for the scale was 0.87. Syptoms of anxiety were
assessed using the State-Trait Anxiety Inventory (STAI; Spielberger, 1983), a 40-item
measure that assesses current symptoms of anxiety and subjects’ global tendency toward
trait anxiety. Cronbach’s alpha for both the state and trait subscales of the STAI was 0.94.
As the two subscales of the STAI were highly correlated (r = 0.80), a composite STAI score
was calculated and used as the outcome variable for all analyses; Cronbach’s alpha for the
composite scale was 0.96.
Global symptoms of psychological distress were assessed using the Brief Symptom
Inventory (BSI; Derogatis & Spencer, 1982), a 53-item measure of psychological symptoms
that reflects nine domains of problems (somatization, obsessiveness, interpersonal
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and
psychoticism). Cronbach’s alpha for the subscales of the BSI ranged from 0.71 to 0.87.
Because the distribution of scores on the BSI subscales was non-normal, the subscales were
coded into dichotomous variables for all analyses. Subjects who rated any item on a
subscale as “quite a bit” or “extremely” distressing received a score of 1, while subjects who
rated all items as “moderately” distressing or lower received a score of 0.
Personality. Personality was assessed using the Big Five Inventory (BFI; John,
Naumann, & Soto, 2008), a 44-item measure that asesses five domains of personality
structure (openness to experience, conscientiousness, extraversion, agreeableness, and
neuroticism). Cronbach’s alpha for the subscales of the BFI ranged from 0.76 to 0.88.
Results and Discussion
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Descriptive statistics for the primary study measures and intercorrelations among
the measures are presented in Table 4. As expected, cognitive risk factors, interpersonal
risk factors, and psychological symptoms were moderately to highly correlated. The
AToM was most highly correlated with the DAS (r = 0.50), followed by symptoms of
depression (r = 0.41) and anxiety (r = 0.41). Meng, Rosenthal, and Rubin’s (1992)
approach for comparing the magnitude of correlation coefficients was used to assess the
difference between these correlations; there was a trend for the AToM to be more
strongly associated with the DAS than with the EPDS (p = 0.06) and the STAI (p = 0.06).
The correlations between the AToM and measures of interpersonal risk, including the
DYAD (r = -0.15) and the MDPSS (r = 0.20) were significantly smaller than the
correlations between the AToM and the DAS and psychological symptoms (all p values <
0.001).
In contrast to the results of Study 1, each of the three subscales of the AToM was
moderately to strongly correlated with the other subscales. Factor 2 of the AToM was
also moderately associated with general cognitive biases in this sample, although the
magnitude of this association was smaller than for Factors 1 and 3. All three factors of
the AToM correlated moderately to highly with general cognitive biases and symptoms
of depression and anxiety. Factors 1 and 2 of the AToM were weakly correlated with
inadequate social support, and Factor 1 of the AToM was weakly associated with low
marital satisfaction. Factors 2 and 3 of the AToM were not associated with marital
satisfaction, and Factor 3 was not associated with inadequate social support.

34
As expected, psychological symptoms were strongly correlated with one another,
Marital satisfaction and social support were moderately correlated with one another.
Factor structure of the AToM.
To assess the stability of the factor structure of the AToM identified in Study 1,
confirmatory factor analysis was use to assess the fit of the original three-factor model
and to compare this model to a one-factor model. The three-factor model was a
marginally acceptable fit to the data , χ2(51) = 202.8, p < 0.001, SRMR = 0.10, CFI =
0.89, RMSEA = 0.10, p < 0.001. Comparison of the three-factor solution to a one-factor
solution indicated that the three-factor solution was a significantly better fit to the data,
χ2(3) = 346.8, p < 0.001.
We also assessed whether the factor structure of the AToM was comparable for
pregnant and postpartum subjects. We first specified a model in which the factor loadings
and factor covariances were allowed to vary freely between the two groups. We then
specified a model in which factor loadings were constrained to be equal between the two
groups. There was not a significant difference in the fit of the constrained model χ2(12) =
16.48, p > 0.05, and the change in the CFI was less than 0.01 (ΔCFI = 0.003), which
indicates that the constrained model has comparable model fit (Cheung & Rensvold,
2002). We then specified a model in which both the factor loadings and the factor
correlations were constrained to be equal between the two groups. There was not a
significant difference in the fit of the constrained model, χ2(3) = 6.82, p > 0.05, and the
change in the CFI was less than 0.01 (ΔCFI = 0.003), which indicates that the constrained
model has comparable model fit (Cheung & Rensvold, 2002). Results of these analyses

35
suggest that the factor structure of the AToM and the correlations among the factors are
comparable for pregnant and postpartum subjects.
Convergent and predictive validity of the AToM.
We conducted a series of multiple regression models to assess the convergent and
predictive validity of the AToM (see Table 5). In Model 1, we assessed the convergent
validity of maternal attitudes (as assessed by the AToM) with general cognitive biases (as
assessed by the DAS). After controlling for demographic variables, dysfunctional
maternal attitudes significantly predicted general cognitive biases (β = 0.50). The
predictive validity of maternal attitudes was assessed using depressive symptoms (Model
2, as assessed by the EPDS) and anxiety symptoms (Model 3, as assessed by the STAI
composite) as outcome measures. After controlling for demographic variables,
dysfunctional maternal attitudes were a significant predictor of both depressive symptoms
(β = 0.43) and anxiety symptoms (β = 0.43).
We then conducted a series of multiple regression models to assess the convergent
and predictive validity of the subscales of the AToM (see Table 5). In Model 4, we
assessed the convergent validity of the three subscales with general cognitive biases (as
assessed by the DAS). After controlling for demographic variables, only beliefs related to
others’ judgments (AToM Factor 1) predicted general cognitive biases. The predictive
validity of the three subscales was assessed using depressive symptoms (Model 5, as
assessed by the EPDS) and anxiety symptoms (Model 6, as assessed by the STAI
composite) as outcome measures. After controlling for demographic variables, beliefs
related to others’ judgments (AToM Factor 1) and beliefs related to maternal

36
responsibility (AToM Factor 2) were significantly associated with depressive symptoms.
Only beliefs related to others’ judgments (AToM Factor 1) were significantly associated
with anxiety symptoms.
A series of multiple regressions were conducted to assess the incremental
predictive validity of maternal attitudes as compared to general cognitive biases and
interpersonal risk factors (marital satisfaction, as assessed by the DYAD, and inadequate
social support, as assessed by the MDPSS, see Table 6). We first conducted hierarchical
multiple regressions in which demographic variables were entered in Step 1, cognitive
biases were added in Step 2, and maternal attitudes were added in Step 3. Separate
regressions were conducted for depressive symptoms (Model 1) and anxiety symptoms
(Model 4). After controlling for demographic variables and general cognitive biases, the
AToM was a significant predictor of both depressive symptoms (β = 0.24) and anxiety
symptoms (β = 0.18). We then conducted hierarchical multiple regressions in which
demographic variables were entered in Step 1, interpersonal risk factors were entered in
Step 2, cognitive biases were entered in Step 3, and maternal attitudes were entered in
step 4. Separate regressions were conducted for depressive symptoms (Model 2) and
anxiety symptoms (Model 5). After controlling for demographic variables, interpersonal
risk factors, and cognitive biases, dysfunctional maternal attitudes were significant
predictors of both depressive symptoms (β = 0.15) and anxiety symptoms (β =0.18). In
order to assess the relative contributions of interpersonal and cognitive risk factors, we
then conducted hierarchical multiple regressions in which demographic variables were
entered in Step 1, maternal attitudes were entered in Step 2, cognitive biases were entered

37
in Step 3, and interpersonal risk factors were entered in Step 4. Separate regressions were
conducted for depressive symptoms (Model 5) and anxiety symptoms (Model 6). Both
inadequate social support and marital satisfaction were significant predictors of
symptoms of depression (βMDPSS = 0.23, βDYAD = -0.17) and anxiety (βMDPSS = 0.27,
βDYAD = -0.19), after controlling for maternal attitudes and general cognitive biases.
We also conducted a series of multiple regressions were conducted to assess the
incremental predictive validity of the three subscales as compared to general cognitive
biases and interpersonal risk factors (marital satisfaction, as assessed by the DYAD, and
inadequate social support, as assessed by the MDPSS) (see Table 7). We first conducted
hierarchical multiple regressions in which demographic variables were entered in Step 1,
cognitive biases were added in Step 2, and the three subscales of the AToM were added
in Step 3. Separate regressions were conducted for depressive symptoms (Model 1) and
anxiety symptoms (Model 4). After controlling for demographic variables and general
cognitive biases, beliefs related to others’ judgments (AToM Factor 1) and beliefs related
to maternal responsibility (AToM Factor 2) were significantly associated with symptoms
of depression. Only beliefs related to others’ judgments (AToM Factor 1) were
significantly associated with symptoms of anxiety.
We then conducted hierarchical multiple regressions in which demographic
variables were entered in Step 1, interpersonal risk factors were entered in Step 2,
cognitive biases were entered in Step 3, and maternal attitudes were entered in Step 4.
Separate regressions were conducted for depressive symptoms (Model 2) and anxiety
symptoms (Model 5). After controlling for demographic variables, interpersonal risk
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factors, and cognitive biases, each of the subscales of the AToM was significantly
associated with symptoms of depression, while only beliefs related to others’ judgments
(AToM Factor 1) were significantly associated with symptoms of anxiety.
In order to assess the relative contributions of interpersonal and cognitive risk factors, we
then conducted hierarchical multiple regressions in which demographic variables were
entered in Step 1, maternal attitudes were entered in Step 2, cognitive biases were entered
in Step 3, and interpersonal risk factors were entered in Step 4. Separate regressions were
conducted for depressive symptoms (Model 5) and anxiety symptoms (Model 6). Both
inadequate social support and marital satisfaction were significant predictors of
symptoms of depression and anxiety after controlling for demographic variables and
cognitive biases. This suggests that both interpersonal and cognitive factors are uniquely
associated with perinatal distress.
Discriminant validity.
To assess the discriminant validity of the AToM, a series of multiple regressions
was conducted to assess the relationship between the AToM and psychological
symptoms, as assessed by the BSI, and personality factors, as assessed by the BFI. The
total AToM score and each subscale of the AToM were assessed as outcomes in separate
regressions, and demographic variables and each of the subscales of the measure (BSI or
BFI) were entered into the model simultaneously. Of the nine subscales of the BSI, only
obsessiveness and hostility were significantly associated with overall dysfunctional
maternal attitudes after controlling for demographic variables and the other subscales of
the BSI (see Table 8). After controlling for demographic variables and the other subscales
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of the BSI, obsessiveness was significantly associated with all three subscales of the
AToM (see Table 8). Hostility was significantly associated with beliefs related to others’
judgments (AToM Factor 1) and beliefs related to maternal responsibility (AToM Factor
2). Paranoia was significantly associated with beliefs related to maternal responsibility
(AToM Factor 2).
Of the five personality factors assessed by the BFI, only neuroticism was
significantly associated with overall dysfunctional maternal attitudes after controlling for
demographic variables and other personality factors (see Table 9). After controlling for
demographic variables and the other subscales of the BFI, neuroticism and extraversion
were associated with beliefs related to others’ judgments (AToM Factor 1); no other
subscales of the BFI were related to other subscales of the AToM (see Table 9).
General Discussion
The results of these studies suggest that dysfunctional attitudes toward
motherhood are a specific predictor of symptoms of depression and anxiety during the
transition to parenthood, even when known risk factors are controlled. In Study 1, we
developed a measure of maternal attitudes that is appropriate for use among first-time
mothers. We demonstrated that the measure has good convergent validity with general
cognitive biases and an existing but flawed measure of maternal attitudes. In Study 2, we
used this measure to assess the relationship between maternal attitudes and psychological
symptoms among pregnant and postpartum first-time mothers. Dysfunctional maternal
attitudes were strongly predictive of both depression and anxiety and demonstrated
incremental predictive validity over and beyond general cognitive biases and
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interpersonal risk factors for these symptoms. Dysfunctional maternal attitudes were
associated with neuroticism, the dimension of personality that is most strongly associated
with depression and anxiety (Kotov, Gamez, Schmidt & Watson, 2010), but were not
associated with other personality factors.
Our findings are consistent with the results of other studies assessing risk factors
for perinatal distress. Reviews of research in this area have consistently found that both
cognitive and interpersonal factors have moderate to large associations with depressive
symptoms (Beck, 2001; O’Hara & Swain, 1996; Robertson et al., 2004). We found that
both cognitive and interpersonal risk factors have unique predictive validity for
symptoms of depression and anxiety, even when other risk factors are controlled for. The
results of these studies build upon this previous literature by demonstrating that a risk
factor specific to the perinatal period, maternal attitudes, has incremental predictive
validity above and beyond these established risk factors.
The results of this study are consistent with Beck’s (1967) cognitive model of
psychopathology, which posits that psychological symptoms occur when maladaptive
beliefs are activated in the context of a relevant stressor. Given the inherently stressful
nature of pregnancy and new motherhood, this model would predict that women with
maladaptive beliefs about motherhood would be at increased risk for depression and
anxiety. While general maladaptive beliefs may also be activated by stressful events
during this time, specific beliefs about motherhood may be most strongly activated by the
particular stressors of pregnancy and parenting. For example, consider the following
subject from the current study: This woman is currently 16 weeks pregnant with her first
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child. Her EPDS score of 5 is in the nondepressed range, and her DAS score of 33 is in
the 16th percentile for our sample. However, her AToM score of 56 places her in the 95th
percentile for our sample. This subject reported that she “almost always” believes “If I
love my baby, I should want to be with him/her all the time.” This subject’s generally low
level of overall cognitive biases may be protective against depression in the context of
other life stressors. However, it is likely that during the postpartum period she will have
the experience of wanting to spend some time away from her baby. Because of her
specific attitudes toward motherhood, she may interpret this desire to mean that she does
not love her child enough, and may then interpret this belief to mean that she is a bad
mother. These beliefs may then lead to symptoms of depression, including feelings of
sadness, guilt and worthlessness.
A major limitation of the current studies is their cross-sectional design. As risk
factors and psychological symptoms were assessed simultaneously, it is impossible to
establish whether dysfunctional maternal attitudes contributed causally to the
development of these symptoms or whether they simply reflect the presence of
depression and anxiety. Future research is necessary to establish whether these
maladaptive beliefs precede the development of symptoms. To address this concern, a
follow-up to the current study is planned in which the pregnant subjects will be contacted
at 12 weeks postpartum. This will allow us to assess whether maternal attitudes during
pregnancy predict changes in symptoms of depression and anxiety during the postpartum
period.
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Another limitation of the current studies was the homogeneity of our subjects.
Participants in these studies were more likely to be white, highly-educated, affluent and
married. The lack of sociodemographic diversity is a demonstrated problem in healthcare
research (Woodall, Morgan, Sloan & Howard 2010). This is particularly relevant to the
current research, as several studies have suggested that different factors may be
predictive of depression and anxiety among ethnic minorities, women of low
socioeconomic status, and women without a partner (e.g. Halbreich, 2005; Logsdon &
Usui, 2001; Seguin, Potvin, St. Denis & Loiselle, 1995; Surkan, Peterson, Hughes &
Gottlieb, 2006). We did not find that demographic characteristics were associated with
psychological symptoms in our sample, but our ability to detect potential differences may
have been limited by the relatively small numbers of single women, racial/ethnic
minorities, and women of low socioeconomic status who participated in these studies.
Further efforts to increase the diversity of participants in this research are necessary in
order to determine whether maternal attitudes are related to demographic characteristics
and whether the role of maternal attitudes may differ among women of different
backgrounds.
The association between dysfunctional maternal attitudes and perinatal distress
may provide clinicians with a means of detecting women at-risk for perinatal depression
and anxiety. There is some evidence that there is a subgroup of women who are
particularly vulnerable to perinatal depressive episodes (Bloch, Schmidt, Danaceau,
Murphy, Nieman, & Rubinow, 2000; Cooper & Murray, 1995). By identifying women
whose beliefs about motherhood may put them at risk for psychological distress during
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pregnancy and the postpartum period, clinicians may be able to intervene early to prevent
symptoms from occurring or reduce their severity or duration. A wide range of preventive
interventions have been found to effectively reduce the prevalence of depressive episodes
during the postpartum period (Sockol, 2012); women with maladaptive beliefs about
motherhood may be likely to benefit from these interventions.
Our findings may also prove useful for clinicians and researchers interested in
developing interventions for perinatal depression and anxiety, particularly cognitivebehavioral interventions. There is some evidence that cognitive-behavioral therapy may
not be as effective for perinatal depression as interpersonal psychotherapy (Sockol,
Epperson, & Barber, 2011). However, researchers have developed a manualized version
of interpersonal psychotherapy specific to perinatal depression that takes into account
common interpersonal challenges that women face during the transition to parenthood
(O’Hara, Stuart, Gorman, & Wenzel, 2000). Our findings provide evidence for themes
that may characterize depressed women’s beliefs about motherhood. While cognitivebehavioral therapy is inherently sensitive to individuals’ particular cognitive biases,
developing specific interventions for perinatal populations that incorporate common
cognitive distortions could lead to improved efficacy of cognitive-behavioral
interventions for this population.
Overall, the results of these studies suggest that dysfunctional maternal attitudes
are strongly associated with psychological symptoms during the perinatal period. While
dysfunctional maternal attitudes are strongly associated with general cognitive biases,
they have incremental predictive validity over these more general beliefs. Moreover,
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dysfunctional maternal attitudes continue to predict symptoms of depression and anxiety
even controlling for interpersonal factors. These findings are consistent with Beck’s
cognitive model of psychopathology. Results of these studies suggest that maladaptive
attitudes toward motherhood are a specific risk factor for perinatal depression and anxiety
that may be used by clinicians and researchers to identify women at-risk for these
disorders and as targets for intervention and prevention. Although further research is
necessary to establish the causal role of these attitudes in the development of
psychological symptoms and to assess whether these beliefs play a similar role among
more diverse populations, these findings indicate that maternal attitudes play an
important role in perinatal depression and anxiety.
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Table 1
Demographic Characteristics of Samples in Studies 1 and 2
Age, M (SD)
Gestational Age (weeks), M (SD)
Infant Age (weeks), M (SD)
Relationship Status
Married
In a relationship, living together
In a relationship, not living together
Other
Race/Ethnicity
Asian/Pacific Islander
Black/African-American
Caucasian
Latina
Annual Household Income
< $25,000
$25,000-$49,999
$50,000-$74,999
$75,000-$99,999
> $100,000
Employment Status
Full-Time
Part-Time
Unemployed
Highest Level of Education
Did Not Complete High School
High School Diploma/GED
Some College
Associate’s Degree/Trade School
Bachelor’s Degree
Graduate or Professional Degree

Study 1
28.3(4.7)
26.1 (8.3)
12.5 (8.2)

Study 2
29.2 (4.8)
24.1 (7.2)
13.9 (7.0)

65%
13%
2%
2%

80%
13%
1%
6%

3%
1%
78%
2%

1%
4%
94%
5%

16%
18%
18%
12%
18%

11%
21%
21%
17%
30%

30%
15%
29%

52%
16%
23%

1%
3%
19%
4%
32%
24%

0%
7%
13%
6%
29%
44%
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Table 2
Common Factor Analysis of Attitudes Toward Motherhood Scale with Promax Rotation
in Study 1
Factor

Promax loading

Item-total r

If I make a mistake, people will think I am a bad mother.

0.85

0.42

People will probably think less of me if I make parenting
mistakes.

0.85

0.42

If my baby is crying, people will think I cannot care for
him/her properly.

0.83

0.32

Seeking help with my baby from other people makes me feel
incompetent.

0.68

0.37

If I love my baby, I should want to be with him/her all the
time.

0.85

0.51

I should feel more devoted to my baby.

0.76

0.33

I am the only person who can keep my baby safe.

0.68

0.47

Good mothers always put their baby’s needs first.

0.66

0.46

It is wrong to feel disappointed by motherhood.

0.88

0.61

It is wrong to have mixed feelings about my baby.

0.84

0.65

Negative feelings towards my baby are wrong.

0.75

0.45

If I fail at motherhood, then I am a failure as a person.

0.69

0.51

Beliefs Related to Others’ Judgments

Beliefs Related to Maternal Responsibility

Beliefs Related to Maternal Role Idealization
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Table 3
Summary Statistics and Intercorrelations Among Maternal Attitudes and General Cognitive Biases in Study 1

AToM Total

n
136

Range
16-58

Others’ Judgments (AToM Factor 1)

136

4-21

Maternal Responsibility (AToM Factor 2)

136

5-24

Role Idealization (AToM Factor 3)

136

4-23

Maternal Attitudes (MAQ)

111

0-15

Cognitive Biases (DAS)

104

64-178

M(SD)
37.22
(8.32)
11.34
(3.84)
14.24
(3.61)
11.65
(3.97)
4.34
(2.77)
119.23
(24.21)

AToM
Total
(.81)

AToM
Factor 1
.62***

AToM
Factor 2
.74***

AToM
Factor 3
.83***

MAQ
.31**

DAS
.43**

.76***

(.82)

.10

.24**

.30**

.53***

.96***

.13

(.74)

.55***

.16

.13

1.03***

.30**

.71***

(.80)

.21*

.27**

.43**

.42**

.23

.30*

(.63)

.27**

.50**

.62***

.16

.32**

.36**

(.90)

* p < 0.05 ** p< 0.01 *** p < 0.001
Note. Uncorrected correlations are displayed above the diagonal. Correlations below the diagonal have been corrected for attenuation. Internal reliability coefficients are displayed in parentheses on the
diagonal.
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Table 4
Descriptive Statistics and Correlations Among Primary Study Measures in Study 2

Maternal Attitudes
(AToM Total)
Others’ Judgments
(AToM Factor 1)
Maternal Responsibility
(AToM Factor 2)
Role Idealization
(AToM Factor 3)
Cognitive Biases
(DAS)
Depressive Symptoms
(EPDS)
Anxiety Symptoms
(STAI)
Marital Satisfaction
(DYAD)
Inadequate Social Support
(MDPSS)

n
288

Range
12-67

293

4-22

290

4-24

292

4-24

237

17-94

278

0-25

240

40-155

211

73-145

229

12-84

M(SD)
38.8
(10.6)
11.5
(3.9)
13.8
(4.3)
13.5
(4.8)
49.2
(16.6)
8.3
(4.8)
73.3
(21.3)
118.8
(14.5)
70.5
(13.9)

AToM
Total
(.86)

AToM
Factor 1
.73***

Atom
Factor 2
.82***

Atom
Factor 3
.87***

DAS
.50***

EPDS
.41***

STAI
.41***

DYAD
-.15***

MDPSS
.20**

.88***

(.80)

.37***

.45***

.57***

.41***

.48***

-.18*

.19**

1.03***

.48***

(.73)

.62***

.31***

.33***

.30***

-.11

.19**

1.04***

.56***

.81***

(.81)

.37***

.25***

.26***

-.09

.12

.57***

.67***

.38***

.43***

(.91)

.49***

.58***

-.33***

.16*

.47***

.49***

.41***

.30***

.55***

(.87)

.79***

-.36***

.30***

.45***

.55***

.36***

.29***

.62***

.86***

(.96)

-.43***

.44***

-.17***

-.21*

-.13

-.10

-.36***

-.40***

-.46***

(.93)

-.21**

.22***

.22**

.23**

.17*

.17*

.33***

.42***

-.22**

(.95)

* p < 0.05 ** p< 0.01 *** p < 0.001
1
Descriptive statistics are presented for the non-transformed MDPSS. As subjects’ scores on the MDPSS were not normally distributed, correlations were calculated using the transformed variable.
Note. Uncorrected correlations are displayed above the diagonal. Correlations below the diagonal have been corrected for attenuation. Internal reliability coefficients are displayed in parentheses on the
diagonal.
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Table 5
Multiple Regressions Assessing the Convergent and Predictive Validity of Maternal Attitudes (AToM) in Study 2

Age
Pregnant vs. Postpartum
Married vs. Nonmarried
White vs. Nonwhite
Maternal Attitudes
(AToM Total)
Others’ Judgments
(AToM1)
Maternal Responsibility
(AToM2)
Role Idealization
(AToM3)
R2
* p < 0.05 ** p< 0.01 *** p < 0.001

Model 1
General
Cognitive Biases
(DAS)
β

Model 2
Depressive
Symptoms
(EPDS)
β

Model 3
Anxiety
Symptoms
(STAI)
β

Model 4
General
Cognitive Biases
(DAS)
β

Model 5
Depressive
Symptoms
(EPDS)
β

Model 6
Anxiety
Symptoms
(STAI)
β

0.12

0.04

0.04

0.10

0.02

0.04

0.11

-0.13

-.06

0.11

-0.10

-0.05

-0.01

-0.01

0.10

0.04

0.03

0.15*

0.07

0.05

0.08

0.04

0.02

0.05

0.50***

0.43***

0.43***
0.50***

0.42***

0.45***

0.11

0.25**

0.15

0.02

-0.11

-0.04

0.35***

0.27***

0.28***

0.27***

0.20***

0.21***
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Table 6
Hierarchical Multiple Regressions Assessing the Incremental Predictive Validity of Maternal Attitudes (AToM Total) in Study 2
Outcome
Model 1a
β
Step 1a/b/c
Age
Pregnant vs. Postpartum
Married vs. Nonmarried
White vs. Nonwhite
Step 2b/4c
Lack of Social Support (MDPSS)
Marital Satisfaction (DYAD)
Step 2a/3b/c
Cognitive Biases (DAS)
Step 2c/3a/4b
Maternal Attitudes (AToM)
Step 1 R2
Step 2 ΔR2
Step 3 ΔR2
Step 4 ΔR2

-0.05
-0.07
0.02
0.09

Depressive Symptoms
(EPDS)
Model 2b
Model 3c
β
β

Model 4a
β

Anxiety Symptoms
(STAI)
Model 5b
β

Model 6c
β

-0.07
-0.02
0.13
0.11

0.01
-0.02
0.14
0.01

0.01
-0.02
0.14
0.01

0.33***
-0.28***

0.27***
-0.19**

0.06
-0.11
0.03
-0.03

0.06
-0.11
0.03
-0.03

0.26**
-0.29***

0.23***
-0.17*

0.50***

0.42***

0.40***

0.58***

0.47***

0.47***

0.24**
0.02
0.24***
0.04**

0.15*
0.02
0.16***
0.15***
0.02*

0.36***
0.02
0.13***
0.12***
0.08***

0.18**
0.04
0.32***
0.02*

0.18*
0.02
0.22***
0.20***
0.02*

0.41***
0.02
0.16***
0.16***
0.12***

* p < 0.05 ** p< 0.01 *** p < 0.001
a
In models 1 and 4, demographic variables were entered in step 1, cognitive biases (DAS) were added in step 2, and maternal attitudes (AToM) were added in step 3.
b
In models 2 and 5, demographic variables were entered in step 1, interpersonal risk factors (MDPSS and DYAD) were added in step 2, cognitive biases (DAS) were added in step 3, and maternal
attitudes (AToM) were added in step 4.
c
In models 3 and 6, demographic variables were entered in step 1, maternal attitudes (AToM) were entered in step 2, cognitive biases (DAS) were added in step 3, and interpersonal risk factors (MDPSS
and DYAD) were entered in step 4.
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Table 7
Hierarchical Multiple Regressions Assessing the Incremental Predictive Validity of Maternal Attitudes (AToM) in Study 2

Model 1a
β
Step 1a/b/c
Age
Pregnant vs. Postpartum
Married vs. Nonmarried
White vs. Nonwhite
Step 2b/4c
Lack of Social Support (MDPSS)
Marital Satisfaction (DYAD)
Step 2a/3b/c
Cognitive Biases (DAS)
Step 2c/3a/4b
Others’ Judgments (AToM1)
Maternal Responsibility (AToM2)
Role Idealization (AToM3)
Step 1 R2
Step 2 ΔR2
Step 3 ΔR2
Step 4 ΔR2

-0.05
-0.07
0.02
0.09

Depressive Symptoms
(EPDS)
Model 2b
Model 3c
β
β

Model 4a
β

Anxiety Symptoms
(STAI)
Model 5b
β

Model 6c
β

-0.07
-0.02
0.13
0.11

0.01
-0.02
0.14
0.00

0.01
-0.02
0.14
0.00

0.33***
-0.28***

0.25***
-0.19**

0.06
-0.11
0.03
-0.03

0.06
-0.11
0.03
-0.03

0.26**
-0.29***

0.16*
-0.16*

0.50***

0.42***

0.32***

0.58***

0.47***

0.38***

0.26***
0.20*
-0.12
0.04
0.24***
0.07***

0.26**
0.20*
-0.20*
0.02
0.16***
0.15***
0.06**

0.45***
0.31**
-0.27**
0.02
0.25***
0.07***
0.025**

0.22**
0.13
-0.08
0.04
0.32***
0.04**

0.26**
0.12
-0.09
0.02
0.22***
0.20***
0.05**

0.49***
0.22*
-0.17
0.02
0.28***
0.09***
0.10***

* p < 0.05 ** p< 0.01 *** p < 0.001
a
In models 1 and 4, demographic variables were entered in step 1, cognitive biases (DAS) were added in step 2, and maternal attitudes (AToM) were added in step 3.
b
In models 2 and 5, demographic variables were entered in step 1, interpersonal risk factors (MDPSS and DYAD) were added in step 2, cognitive biases (DAS) were added in step 3, and maternal
attitudes (AToM) were added in step 4.
c
In models 3 and 6, demographic variables were entered in step 1, maternal attitudes (AToM) were entered in step 2, cognitive biases (DAS) were added in step 3, and interpersonal risk factors (MDPSS
and DYAD) were entered in step 4.

61
Table 8
Multiple Regressions Predicting Maternal Attitudes (AToM Total and Subscales) from
Psychological Symptoms (BSI Subscales) in Study 2

Age
Pregnant vs. Postpartum
Married vs. Nonmarried
White vs. Nonwhite
Somatization
Obsessiveness
Interpersonal Sensitivity
Depression
Anxiety
Hostility
Phobic Anxiety
Paranoia
Psychoticism
R2
* p < 0.05 ** p< 0.01 *** p < 0.001

Maternal
Attitudes
(AToM
Total)
β
-0.13
0.05
0.05
0.04
-0.03
0.26**
-0.07
0.07
-0.03
0.22**
0.15
-0.13
0.09
0.26***

Others’
Judgments
(AToM
Factor 1)
β
-0.03
0.04
-0.10
0.06
0.01
0.20*
-0.07
0.14
0.00
0.26**
0.08
-0.04
0.02
0.21***

Maternal
Responsibility
(AToM Factor
2)
β
-0.16*
-0.06
0.09
0.07
0.01
0.22**
-0.05
0.05
-0.07
0.20*
0.14
-0.21**
0.06
0.22***

Role
Idealization
(AToM
Factor 3)
β
-0.13
0.11
0.11
-0.01
-0.08
0.21*
-0.04
0.01
-0.01
0.09
0.14
-0.11
0.14
0.18***
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Table 9
Multiple Regressions Predicting Maternal Attitudes (AToM Total and Subscales) from
Personality Factors (BFI Subscales) in Study 2

Age
Pregnant vs. Postpartum
Married vs. Nonmarried
White vs. Nonwhite
Openness
Conscientiousness
Extraversion
Agreeableness
Neuroticism
R2
†

p < 0.10 * p < 0.05 ** p< 0.01 *** p < 0.001

Maternal
Attitudes
(AToM
Total)
β
-0.20**
0.05
0.06
0.05
-0.10
0.02
-0.05
-0.11
0.20*
0.14**

Others’
Judgments
(AToM
Factor 1)
β
-0.10
-0.04
-0.04
0.07
-0.01
0.01
-0.07
-0.17*
0.26**
0.16***

Maternal
Responsibility
(AToM Factor
2)
β
-0.21**
-0.03
0.09
0.09
-0.14
-0.02
-0.04
-0.04
0.13
0.13**

Role
Idealization
(AToM
Factor 3)
β
-0.17*
0.10
0.10
-0.02
-0.11
0.07
-0.03
-0.07
0.12
0.09†

63

Chapter 2:
A Meta-Analysis of Treatments for Perinatal Depression

This chapter originally appeared as:
Sockol, L.E., Epperson, C. N., & Barber, J. P. (2011). A meta-analysis of treatments for
perinatal depression. Clinical Psychology Review, 31, 839-849.

64
Abstract
This meta-analysis assessed the efficacy of pharmacologic and psychological
interventions for the treatment of perinatal depression. A systematic review identified 27
studies, including open trials (n = 9), quasi-randomized trials (n = 2), and randomized
controlled trials (n = 16) assessing change from pretreatment to posttreatment or
comparing these interventions to a control group. Uncontrolled and controlled effect sizes
were assessed in separate meta-analyses. There was significant improvement in
depressive symptoms from pretreatment to posttreatment, with an uncontrolled overall
effect size (Hedges’ g) of 1.61 after removal of outliers and correction for publication
bias. Symptom levels at posttreatment were below cutoff levels indicative of clinically
significant symptoms. At posttreatment, intervention groups demonstrated significantly
greater reductions in depressive symptoms compared to control groups, with an overall
controlled effect size (Hedges’ g) of 0.65 after removal of outliers. Individual
psychotherapy was superior to group psychotherapy with regard to changes in symptoms
from pretreatment to posttreatment. Interventions including an interpersonal therapy
component were found to have greater effect sizes, compared to control conditions, than
interventions including a cognitive-behavioral component. The implications of the
findings for clinical practice and future research are discussed.
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A Meta-Analysis of Treatments for Perinatal Depression
Perinatal depression is one of the most common complications of childbearing.
Approximately 10 to 15% of women experience a clinically significant major depressive
episode during pregnancy or the early postpartum period (Bennett, Einarson, Taddio,
Koren, & Einarson, 2004b; Epperson, 1999; Gavin, Gayner, Lohr, Meltzer-Brody,
Gartlehner, & Swinson, 2005; O’Hara & Swain, 1996). These prevalence estimates
predominantly reflect rates of depressive symptoms in developed countries; there is
evidence that rates of depression vary more widely in non-developed countries
(Halbreich & Karkun, 2006). In addition to the distress and impairment experienced by
depressed women, depression during this time period is associated with further adverse
outcomes for both mother and child. Women who experience perinatal depressive
episodes are at increased risk for subsequent episodes of both postpartum and nonpostpartum depression (Cooper & Murray, 1995). Prenatal depression is associated with
increased risk for negative birth outcomes, including preterm labor, low birthweight, and
intrauterine growth restriction (Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010).
Maternal depression during the postpartum period is also a risk factor for a range of
adverse child outcomes, including behavioral problems and impaired cognitive
development (Grace, Evindar, & Stewart, 2003).
Given the prevalence of perinatal depression and the adverse effects this disorder
has on women and their children, the identification of effective treatments for this
disorder has important public health implications. Although there is a great deal of
evidence for the efficacy of both antidepressant medication and psychological
interventions for depression (see Joffe, Sokolov & Streiner, 1996 and Cuijpers, van
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Straten, Andersson, & van Oppen, 2008 for meta-analyses of the efficacy of
antidepressant medication and psychotherapy for depression, respectively), concerns
unique to the perinatal period may influence the efficacy of these treatments for this
population (Kim, O’Reardon, & Epperson, 2010). For example, in an attempt to limit
fetal exposure, antidepressants may be prescribed below therapeutic dosage levels
(Bennett, Einarson, Taddio, Koren, & Einarson, 2004a). This problem is complicated
further by the fact that most women actually require higher doses of antidepressant
medication during pregnancy (Dawes & Chowienczyk, 2001; Hostetter, Stowe, &
Strader, 2000; Wisner, Perel, & Wheeler, 1993). Concerns regarding the effects of infant
exposure to antidepressant medication via breastmilk may also lead clinicians to
prescribe inadequate doses of these medications during the postpartum period (Epperson,
Anderson, & McDougle, 1997; Epperson, Jatlow, Czarkowski, & Anderson, 2003).
Biological and psychosocial changes that occur in the context of pregnancy and
parenting, including sleep deprivation, disruptions to the hormonal milieu, alterations to
HPA axis functioning, and changes to interpersonal relationships, introduce challenges
that may affect the efficacy of both pharmacological and psychotherapeutic interventions
(Dennis & Ross, 2005; Kammerer, Taylor, & Glover, 2006). The efficacy of
psychological interventions for depression may also be reduced among women who have
had previous pregnancy losses, complications, or traumatic deliveries, as they may
experience post-traumatic stress disorder or other comorbid anxiety disorders (Forray,
Mayes, Magriples, & Epperson, 2009). There are also differences in the acceptability of
interventions, particularly among women who are pregnant or breastfeeding: the majority
of women indicate a preference for psychological interventions to antidepressant
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medication during both pregnancy and the postpartum period, and the overall
acceptability of antidepressant medication among these groups is low (Chabrol,
Teissedre, Armitage, Danel & Walburg, 2004; Kim et al., 2011). Thus the identification
of efficacious interventions, particularly psychological interventions, for this population
is an important and growing area of research.
Two meta-analytic reviews of psychological treatments for postpartum depression
have found these interventions to be superior to routine care or control conditions. A
Cochrane review of psychological and psychosocial interventions for postpartum
depression found that, compared to routine care, these interventions were associated with
a 30% reduction in relative risk for depressive symptomatology (Dennis & Hodnett,
2007). Cuijpers, Brännmark, and van Straten (2008) conducted a meta-analysis of 17
studies in which a psychological intervention initiated during the postpartum period was
compared to a control or active treatment condition. They reported that psychological
interventions were superior to control conditions, with an overall effect size in the
moderate range.
In the only published meta-analysis to include interventions for both antenatal and
postpartum depression, Bledsoe and Grote (2006) evaluated the efficacy of 16
psychological and pharmacological interventions and found that depressive symptoms
decreased significantly from pre- to posttreatment. They did not assess the effect of
treatments compared to control conditions. While their findings provide preliminary
evidence for the efficacy of these interventions, a major limitation of their meta-analysis
is the difficulty of interpreting effect sizes representing changes in symptoms from
pretreatment to posttreatment. As there is evidence that, for many women, depressive
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symptoms remit naturally over the course of the postpartum period, it is not possible to
determine whether these effect sizes reflect the effects of the interventions or simply
natural decreases in symptom levels over time (Heron, O’Connor, Evans, Golding, &
Glover, 2004). The authors also did not report analyses of homogeneity, tests for outliers
or publication bias, did not specify whether the analysis was conducted using fixed or
random effects models, and included multiple effect sizes for three studies in which more
than one active intervention was assessed. As these methodological issues may
substantially impact estimation of effect sizes, these results should be interpreted with
caution.
The present meta-analysis addresses several of the limitations of the above
studies. Unlike Cuijpers, Brännmark, and van Straten (2008), we included
pharmacological interventions in addition to psychological interventions, and included
interventions initiated during pregnancy. As many studies of interventions for this
population are either open trials or do not include a no-treatment control condition, we
elected not to restrict these analyses to studies in which interventions were compared to a
control condition. However, to address the possibility that effect sizes calculated from
these studies may reflect natural symptom remission over time, we also compared active
treatments to control conditions in studies where it was possible to do so. We have also
included several new studies of treatments for perinatal depression that have been
published since these earlier meta-analyses were conducted. The goal of the current metaanalysis was to assess the efficacy of psychological and pharmacological interventions
for perinatal depression, defined as the period encompassing pregnancy and the first 12
months postpartum. Both the overall effect of these interventions on depressive
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symptoms over time and the relative efficacy of interventions compared to control
conditions were assessed. We also conducted exploratory moderator analyses assessing
elements of both study design and interventions as potential moderators of the magnitude
of effect size when significant heterogeneity of effect sizes was observed.
Method
Search Procedures and Selection of Studies
Relevant studies were identified through searches of databases through September
2010, including PubMed and PsycInfo, using the following terms as descriptors:
postpartum depression, pregnancy AND depression, therapy, drug therapy, cognitive
behavior therapy, interpersonal psychotherapy, psychodynamic therapy, treatment, and
treatment outcome. The reference lists of existing meta-analyses, reviews, chapters, and
retrieved articles were inspected for further studies. Clinical trial databases (including the
Cochrane Pregnancy and Childbirth Group, Cochrane Depression, Anxiety and Neurosis
Group, and the International Standard Randomised Controlled Trial Number Register)
were also reviewed for eligible studies.
To be included in the meta-analysis, studies had to meet the following inclusion
criteria:
(a) Used a prospective pretreatment-posttreatment, quasi-randomized trial or randomized
controlled trial design.
(b) Assessed the impact of antidepressant treatment or specified/manualized
psychological intervention for perinatal depression. Hormonal pharmacological
interventions, such as estrogen therapy, were excluded. Nonspecific psychosocial
interventions, such as peer support groups, were excluded. Interventions that did not
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explicitly target depressive symptoms, such as smoking cessation programs, were also
excluded.
(c) Subjects were limited to women with unipolar depression (defined by diagnostic
criteria or symptom severity) during pregnancy or the postpartum period (defined as
the 12 months following the birth of a child).
(d) Reported outcomes for depressive symptoms using a validated self-report or clinicianadministered measure.
(e) Reported sufficient outcomes to allow for the calculation of either uncontrolled or
controlled effect sizes.
A flow chart depicting the search process and exclusion of studies is presented in
Figure 1. After removal of duplicates, the search procedure yielded 1447 studies. The 152
studies whose abstracts indicated evaluation of an intervention for antenatal or postnatal
depression were obtained and reviewed for inclusion. Of these 152 studies, 122 were
excluded for the following reasons: described an intervention without reporting results of
an evaluation (n = 10), study design was not a prospective pretest-posttest, quasirandomized or randomized controlled trial (e.g., retrospective chart reviews, n = 14),
prevention studies that included women without elevated depressive symptoms or a
diagnosis of depression (n = 30), no pharmacological or psychological intervention (e.g.,
exercise, hormonal, and social support interventions, n = 47), population was not
restricted to women during the perinatal period or with unipolar depression (n = 7),
studies that reported only qualitative data (n = 3) or insufficient data for the calculation of
effect sizes (n = 8), and secondary sources for included studies that did not report
outcomes relevant to the analyses (n = 3). The remaining 30 articles, representing 27
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studies, were eligible for inclusion in the meta-analysis. When a secondary source was
available for a given study, the primary source was used to calculate the effect size unless
reported data was insufficient. Sufficient outcome measures for calculation of effect sizes
representing change from pretreatment to posttreatment were reported in 25 studies, and
14 studies reported sufficient outcome measures for calculation of effect sizes
representing the difference between treatment and control conditions at posttreatment.
Coding of Studies
All studies were coded for: intervention type (antidepressant medication vs.
psychotherapy vs. combined), study design (open trial vs. quasi-randomized trial vs.
randomized controlled trial), type of control group (treatment as usual vs. enhanced
treatment as usual vs. waiting list vs. active), population (antepartum vs. postpartum),
outcome measure, whether the study required a clinician-verified diagnosis of depression
for inclusion, treatment length (weeks), and percent attrition. Studies including a
psychological intervention were also coded for therapeutic orientation, whether therapy
was conducted individually or in a group format, and the location in which therapy was
administered (clinic vs. home vs. school). As a majority of studies included the
Edinburgh Postnatal Depression Scale (EPDS) as an outcome measure, this measure was
used to calculate effect sizes for all studies reporting EPDS outcomes. For studies that did
not include the EPDS as an outcome measure, or for which effect sizes could not be
calculated using the reported EPDS values, the primary outcome measure was used.
Effect sizes and moderators were coded by the first author. Three of the variables
included in the moderator analyses were also coded by a second rater, who was trained in
the coding scheme and utilized a written coding manual. Observed agreement was 27/27
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for each variable, or 100%. As all of the variables that were coded for use in the
moderator analyses were objective variables that were explicitly specified in the studies
and required minimal judgment on the part of the coder, this reliability check was
considered adequate.
Analyses
Two separate analyses were conducted. The first analysis assessed the change in
depressive symptoms from pretreatment to posttreatment using the standardized mean
gain score for all treatment groups. To differentiate these analyses from those comparing
treatment to control conditions, these within group effect sizes will be referred to as
“uncontrolled effect sizes” (Feske & Chambless, 1995). To ensure the independence of
included effect sizes, a single effect size was calculated on the basis of the overall mean
and standard deviation of the total group of treated subjects in studies that included more
than one active treatment. Uncontrolled effect sizes were calculated by dividing the mean
change from pretreatment to posttreatment by the pooled standard deviation of the
difference score, corrected for upward bias using Hedges’ g (Hedges, 1981):
[

⁄√

))

]

where the pooled standard deviation is defined as
√
and
)
Uncontrolled effect sizes were calculated so that positive effect sizes represented a
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decrease in depressive symptoms from pretreatment to posttreatment.
None of the studies included in the meta-analysis reported the pretest-posttest
correlation for the sample or data that would allow this value to be calculated. Following
the recommendations of Lipsey and Wilson (2001), the test-retest reliability of the
measures was used as a proxy for the pretest-posttest correlation. These values were
estimated from published validation studies of each measure; when multiple test-retest
reliabilities were available for a single measure, r was computed as the weighted mean of
the reliabilities. As it is likely that these values are inflated estimates of the pretestposttest correlation, the overall analyses were also conducted using values of 0.3, 0.5, and
0.8 as estimates of low, medium, and high correlations, respectively. There were no
substantive differences between these effect sizes, suggesting that using the test-retest
correlations as a proxy for this value would not impact the results of the analyses.
The second analysis compared the efficacy of active treatments to control
conditions using the standardized mean group difference. To differentiate these effect
sizes from those defined previously, these between group effect sizes will be referred to
as “controlled effect sizes” (Feske & Chambless, 1995). Means and standard deviations
for the total group of treated subjects were calculated for all studies in which multiple
active treatments were compared to a control group in order to ensure the independence
of effect sizes. Controlled effect sizes were calculated by dividing the difference between
treatment and control means by the pooled standard deviation, corrected for upward bias
using Hedges’ g (Hedges, 1981):
[

]
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where the pooled standard deviation is defined as
√

)

)
)

and cm is defined as described above. Controlled effect sizes were calculated so that
positive effects represented lower scores in the intervention group compared to the
control group.
The heterogeneity of effect sizes was examined using the Q statistic and the I2
index. Significant Q statistics indicate that the observed range of effect sizes is
significantly larger than would be expected based on within-study variance. While a
significant Q statistic indicates heterogeneous effect sizes, nonsignificant Q statistics
should be interpreted with caution, as heterogeneous effect sizes may yield a
nonsignificant Q value due to low power. The I2 value indicates the proportion of
variance in effect sizes accounted for by between-study variance. The index has a range
from 0 to 100; Higgins and colleagues (2003) suggest that 25, 50 and 75% I2 values
indicate low, medium and high levels of hetereogeneity, respectively.
When analyses indicated significant heterogeneity among effect sizes, exploratory
analyses were conducted to assess for moderators of effect size. Categorical moderators
were assessed using an analysis of variance (ANOVA) of mixed-effects models for each
variable hypothesized to influence the effect size. Meta-regression analyses were
conducted to assess the effects of continuous moderators. Two types of moderators were
included in the analyses. The first were variables that reflected elements of the research
design of included studies; significant findings of moderation would indicate that
differences in effect sizes could be attributed to methodological variability among studies
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(e.g., whether studies required a clinician-verified diagnosis for inclusion). The second
were variables related to characteristics of interventions; for example, pharmacotherapy
versus psychotherapy and differences between psychological interventions of different
therapeutic orientations. For studies assessing psychotherapeutic interventions, we also
assessed whether characteristics of the intervention (including the mode of
administration, location the intervention was delivered, and therapeutic orientation) were
related to effect size.
Calculations of weighted mean effect sizes, heterogeneity, and moderators were
conducted using Comprehensive Meta-Analysis, version 2.2.046 (Borenstein, Hedges,
Higgins, & Rothstein, 2005). A decision was made to estimate overall effect sizes using
random effects models, as it was presumed that the included studies represent a
distribution of true intervention effects. Fixed effect models assume that variability in
effect sizes is due to random error within studies, and that there is a common true effect
size across all studies. The overall effect size represents the estimate of the true effect
size for the population of studies, but is not generalizable beyond the sample of included
studies. In contrast, random effects models assume that variability in effect sizes is due to
both random error within studies and systematic variability between studies – the true
effect size is allowed to vary across studies. The overall effect size represents the
estimated average of the true effect sizes, and results can be generalized to studies not
included in the analysis. Considerable heterogeneity of effect sizes was expected given
the differences in study design, interventions, and samples across the included studies. As
the Q statistic is underpowered in cases of small sample size, random effects models were
estimated regardless of the observed heterogeneity.
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For each of these analyses, the presence of outliers was assessed using the
sample-adjusted meta-analytic deviance (SAMD) statistic (Huffcutt & Arthur, 1995). A
more conservative cutoff score of 2.58 was used to consider studies for exclusion from
the analyses, as extreme values can result from either true population variability or error,
and removing outliers whose effects represent true variability limits the ability to assess
the role of moderators (Beal, Corey & Dunlap, 2002). The SAMDs were rank-ordered
and the scree plots examined to confirm the outlier status of studies with SAMDs above
this cutoff. In cases where the SAMD value was greater than 2.58 but the scree plot
suggested that the SAMD was not discrepant from the overall distribution, the study was
retained to maximize the variance available to assess the role of moderators.
Publication bias was assessed by visual examination of funnel plots, Duval and
Tweedie’s (2000) trim-and-fill procedure, and classic fail-safe N values (Rosenthal,
1979). First, the effect size for each study was plotted against the study standard error. An
asymmetric distribution suggests missing studies due to publication bias. When
asymmetry is present, Duval and Tweedie’s (2000) trim-and-fill procedure provides an
effect size estimate that corrects for the number and assumed location of the missing
studies. When this test indicated significant asymmetry in the funnel plot, the overall
estimates for the model were calculated using the trim-and-fill correction. The fail-safe
value determines the number of studies with null findings that would be necessary to
produce a nonsignificant overall effect size. Using Rosenthal’s (1991) recommendation, a
value of 5K + 10, where K is the number of observed studies, was used as the cutoff for
an unlikely number of studies.
Results
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Study Characteristics
Table 1 displays characteristics of the 27 studies included in the analyses. Of the
included studies, 9 were open trials (33%), 2 were quasi-randomized trials (7%), and 16
were randomized controlled trials (59%). Nineteen studies assessed psychological
interventions (70%), four assessed pharmacological interventions (15%), and four
assessed interventions including psychological and pharmacological components (15%).
Most studies targeted postpartum depression (n = 22, 81%), four targeted antenatal
depression (15%), and one study included subjects across the perinatal period. Length of
treatment ranged from 6 to 16 weeks, with an average of 10 weeks. Interpersonal
psychotherapy (IPT) was the most common psychological intervention (n = 11, 41%),
followed by cognitive-behavioral (CBT) interventions (n = 9, 33%); other interventions
included non-directive counseling (n = 3), a Mother-Infant Therapy Group (n = 1), a
CBT-oriented psychoeducational group (n = 1), manualized supportive psychotherapy (n
= 2), and psychodynamic therapy (n = 2). Nine studies assessed group interventions
(33%), 4 included home-based interventions (15%), and one study included a schoolbased intervention.
Table 2 presents characteristics of the included studies indicative of their
methodological quality. Given the range of designs that were included in the analyses,
methodological quality was not quantified or used in the weighting of effect sizes. Of the
27 included studies, 19 included intent-to-treat analyses. As the average attrition rate was
21%, it is likely that completer analyses represent biased outcomes. In 8 studies, subjects
were not excluded if they were currently receiving additional treatment for depression, all
of which were studies of psychological interventions. In some trials, rates of concurrent
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antidepressant use were quite high (e.g., 54% across both intervention and control groups,
Klier, Muzik, Rosenblum, & Lenz, 2001). While some studies specifically assessed the
potential effect of concurrent antidepressant use on outcome (e.g., Honey, Bennett, &
Morgan, 2002), the inclusion of subjects receiving adjunctive pharmacological treatment
in trials assessing psychological interventions is a significant limitation of the research
base for these interventions. Among the 23 studies that included a psychological
intervention, most studies provided information regarding therapist characteristics and
use of therapy manuals. Fifteen studies provided information about therapist training, 13
indicated that therapists received regular ongoing supervision, and 9 studies assessed for
adherence to the treatment model. Among the 8 studies that included a pharmacological
intervention, only 3 included a placebo condition in which both patients and clinicians
were blind to medication status.
The included studies vary widely in the demographic characteristics and
variability of their samples. Most studies were conducted in the United States (n = 13,
48%), six studies were conducted in Australia (22%), three studies in the United
Kingdom (11%), and the remaining studies were conducted in Austria (n = 1), Canada (n
= 1), France (n = 1), and Sweden (n = 2). Fourteen studies (52%) reported at least some
information regarding the race, ethnicity, or national origin of subjects. In the 10 studies
(37%) that reported demographic information that provided sufficient data regarding the
racial composition of their samples, the percentage of subjects who identified as
racial/ethnic minorities ranged from 0% (Klier et al., 2001) to 100% (Miller et al., 2008),
with a mean of 45.6% and standard deviation of 32.7%. Twenty-three studies (85%)
reported information regarding the marital status of subjects. The percentage of single
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subjects in these studies ranged from 0% (O’Hara et al., 2000, who required women to be
married of living with a partner for 6 months or more to be eligible to participate) to
72.7% (Miller et al., 2008). Twenty studies (74%) reported information regarding parity
or the number of children in subjects’ households. Of the 14 studies that reported the
percentage of primiparous subjects, this value ranged from 25% (O’Hara et al., 2000) to
85.1% (Wiklund, Mohlkert, & Edman, 2010), with a mean of 55.8% and standard
deviation of 17.7%.
Uncontrolled Effect Sizes
Table 3 presents the results of the random effects model for uncontrolled effect
sizes, representing results from 25 studies. These values should be interpreted with
caution, as they reflect within-study change and cannot differentiate between reductions
in symptoms that occurred as a result of the intervention versus the passage of time. All
studies demonstrated significant positive effects, indicating improvement over
pretreatment scores, with Hedges’ g ranging from 0.78 to 4.39. Two studies had SAMD
values greater than 2.58. Visual inspection of the scree plot of the rank-ordered SAMD
scores suggested that the value for the study by Grote and colleagues (2009) was
consistent with the overall distribution of SAMD scores, while the study by Appleby and
colleagues (1997) was discrepant. This study was excluded from subsequent analyses; the
average effect size excluding this outlier was 1.54 (95% CI 1.34-1.73, p < 0.001).
The Q statistic indicated that there was significant heterogeneity among the effect
sizes (p < 0.001). The I2 value indicated a high level of heterogeneity, with 86% of the
variance in effect sizes attributable to between-study variance. The fail-safe value was
9102, far exceeding the tolerance level for an unlikely number of non-significant studies
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(130). The funnel plot was slightly asymmetric; trim-and-fill procedures suggested that
two studies with effect sizes to the right (more strongly positive) of the mean were
missing. The corrected average effect size was 1.61 (95% CI 1.40-1.81). This adjusted
value suggests that if the included studies do reflect a publication bias, it is in the
direction of underestimating the true effect size of the interventions.
As the magnitude of uncontrolled effect sizes is difficult to interpret, a separate
meta-analysis was conducted to determine the average level of depressive symptoms at
posttreatment. A random effects model was used to calculate the overall mean for the 15
studies that used the EPDS as an outcome measure. The average score at posttreatment
was 8.62 (95% CI 7.66-9.58), which is below the commonly used cutoff of 11-13
considered indicative of clinically significant depressive symptoms (Cox, Chapman,
Murray, & Jones, 1996). A second random effects model was used to calculate the
overall mean for the 5 studies that used the Hamilton Depression Rating Scale as an
outcome measure. The average score at posttreatment was 6.12 (95% CI 2.90-9.33),
which is also below the cutoff of 7 commonly considered indicative of symptom
remission (Frank et al., 1991).
Moderator Analyses: Uncontrolled Effect Sizes
As both the Q statistic and I2 index indicated significant heterogeneity of effect
sizes, exploratory analyses of potential moderators were conducted. These analyses
assessed whether effect sizes differed on the basis of characteristics of the included
studies and interventions. As the reporting of sample characteristics was inconsistent
across studies, none of these variables were assessed as potential moderators. Subgroups
including only one study were excluded from moderator analyses.
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Study characteristics. Four characteristics of the included studies were assessed
as potential moderators: study design, type of sample, whether a clinician-verified
diagnosis of a depressive disorder was required for inclusion in the study, and outcome
measure (see Table 4). No significant differences in the average effect size were found
among the three types of study designs, between studies assessing interventions for
antenatal depression versus postpartum depression, or between studies that did and did
not require a clinician-verified diagnosis for inclusion. Studies for which the effect size
was calculated using the BDI had significantly smaller effect sizes (g = 1.10, n = 2) than
studies for which the effect size was calculated using the EPDS (g = 1.62, n = 16) or
HDRS (g = 1.65, n = 5).
Intervention variables. Two characteristics of the interventions were assessed
for potential moderation (see Table 4). Studies including three types of interventions
were compared: pharmacological, psychological, and combined (pharmacological +
psychological). There were no significant differences in effect sizes among the three
major types of interventions. Meta-regression analysis was used to assess the relationship
between length of treatment and effect size. There was a trend for a positive association
of length of treatment with effect size; however, this result did not reach significance
(slope = 0.03, p = 0.07).
For studies that included a psychological intervention, three characteristics of the
intervention were assessed for moderation: method of administration (individual vs.
group), location of administration (clinic vs. home), and therapeutic orientation. Studies
in which therapy was administered individually had significantly larger effect sizes (g =
1.79, n = 12) than those utilizing a group therapy format (g = 1.23, n = 7). There was a
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trend (p = 0.08) toward home-administered treatments (g = 2.33, n = 2) having larger
effect sizes than clinic-based treatments (g = 1.64, n = 16).
Four analyses were conducted to assess whether inclusion of two well-established
therapeutic interventions, cognitive-behavioral therapy (CBT) or interpersonal
psychotherapy (IPT), was a moderator of effect size. First, studies were categorized as
either including or not including each approach. There was a trend for studies that
included one of these interventions having larger effect sizes (g = 1.61, n = 18) than
studies that included other psychological interventions (g = 1.11, n = 2). There were not
significant differences between studies that included CBT compared to those that did not
(including IPT interventions) or between studies that included IPT compared to those that
did not (including CBT interventions). Finally, the effect sizes of studies including CBT
and IPT were compared to one another. No study included both a CBT and an IPT
intervention. There was not a significant difference in the average effect size of the two
interventions.
Controlled Effect Sizes
Table 5 presents the results of the random effects model for controlled effect
sizes, representing results from 14 studies. All effect sizes were positive, indicating
superiority of treatment to control conditions, with Hedges’ g ranging from 0.31 to 2.33.
Two studies had SAMD values greater than 2.58. Visual inspection of the scree plot of
the rank-ordered SAMD scores indicated that the value for the study by Milgrom and
colleagues (2005) was consistent with the overall distribution of SAMD scores, while the
study by Chabrol and colleagues (2002) was discrepant. This study was excluded from
subsequent analyses. The average effect size, excluding the outlier, was 0.65 (95% CI
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0.45-0.86, p < 0.001). Cohen’s U3 metric provides an intuitive metric through which to
interpret the magnitude of this effect size; this value indicates that 74% of subjects in
treatment conditions could be expected to report levels of depressive symptoms lower
than the mean of the control group (Lipsey & Wilson, 2001).
The Q statistic indicated that there was significant heterogeneity among the effect
sizes (p < 0.05). The I2 value indicated a medium level of heterogeneity, with 43% of the
variance in effect sizes attributable to between-study variance. The fail-safe N was 229,
which substantially exceeds the tolerance level for an unlikely number of non-significant
studies (75). The funnel plot was symmetric and the trim-and-fill procedures suggested
no missing studies.
Moderator Analyses: Controlled Effect Sizes
As both the Q statistic and I2 value indicated heterogeneity among effect sizes,
exploratory analyses of potential moderators were conducted to assess whether effect
sizes differed on the basis of study or intervention characteristics. Subgroups including
only one study were excluded from moderator analyses.
Study characteristics. As for uncontrolled effect sizes, target population,
diagnostic status, and outcome measure were assessed as potential moderators (see Table
6). In addition, the average effect size for studies utilizing different control groups
(treatment as usual vs. enhanced treatment as usual vs. waiting list control) was assessed.
The only significant moderator of effect size was the target population of the study;
interventions for antenatal depression had significantly larger effect sizes (g =1.18, n = 2)
than those for postpartum depression (g = 0.57, n = 11).
Intervention variables. As only one study assessing pharmacological treatment
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was included in this analysis, it was not possible to compare the average effect size for
pharmacological vs. psychological interventions. Length of treatment was assessed for
moderation using meta-regression analysis; treatment length was not significantly
associated with effect size (slope = 0.05, p = 0.12).
For the studies assessing psychological interventions, three potential moderators
were assessed (see Table 6). There were no significant differences among average effect
sizes with respect to the method of administration of therapy (individual vs. group vs.
combined). There was a trend for studies that included clinic-based interventions to have
larger effect sizes (g = 0.73, n = 9) than studies that included home-based interventions (g
= 0.38, n = 2). Studies that included an IPT intervention were compared to those that
included a CBT intervention. As only one study included an intervention representing
different therapeutic orientation, analyses comparing IPT and CBT separately to all other
treatments combined were not conducted. Studies that included an IPT intervention had
significantly larger effect sizes (g = 0.96, n = 5) than those that included a CBT
intervention (g = 0.40, n = 6).
Discussion
The results of these analyses provide evidence for the efficacy of a range of
interventions for perinatal depression. All studied interventions demonstrated
symptomatic improvement from pretreatment to posttreatment, with posttreatment means
for both the EPDS and HDRS below cutoffs for clinically significant depressive
symptoms. All interventions also demonstrated superiority to control conditions, with an
overall effect size in the moderate range. The overall effect size (g = 0.65) is comparable
to that found in a meta-analysis of the efficacy of psychological treatments for adult
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depression, which reported an average posttreatment effect size of 0.67 (Cuijpers, Smit,
Bohlmeijer, Hollon, & Andersson, 2010).
Our finding indicating the superiority of IPT to CBT for the treatment of perinatal
depression has important implications for both clinicians and researchers. This is
consistent with the findings of Bledsoe and Grote (2006), who reported that IPT
interventions were associated with greater decreases in symptoms from pretreatment to
posttreatment; our study is the first to find that IPT results in a greater reduction in
symptoms compared to control conditions, as well. It is possible that this finding reflects
a true difference in the efficacy of a specific form of psychotherapy for this population. In
describing their adaptations of IPT for postpartum depression, Stuart and O’Hara (1995)
noted that the focus on interpersonal problem areas, particularly role transitions and
interpersonal disputes, may be particularly well-suited to the problems women experience
during the perinatal period, such as disruptions in their interpersonal relationships. While
a possible interpretation of this finding is that IPT is a more efficacious intervention for
depression among this population, our findings may also have resulted from
characteristics of the included studies unrelated to the interventions themselves. Studies
assessing an IPT intervention were more likely to report utilization of a therapy manual;
the implementation of manualized IPT for this population is likely facilitated by the ready
availability of a treatment manual containing specific adaptations for postpartum
depression (O’Hara, Stuart, Gorman, & Wenzel, 2000). It is unclear whether studies of
CBT interventions did not utilize a specific therapy manual or whether these studies
simply followed widely accepted and available manuals for CBT for depression (e.g.,
Beck, Rush, Shaw, & Emery, 1987). Studies assessing a CBT intervention were also
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more likely to include other interventions, either as an explicit element of the intervention
itself (e.g., Honey, Bennett, & Morgan, 2002¸ whose intervention included educational,
cognitive-behavioral, and relaxation components), or because a single effect size was
calculated for studies including multiple active treatments for the purpose of our analyses
(e.g., Cooper, Murray, Wilson, & Romaniuk, 2003, who included CBT, psychodynamic,
and nondirective counseling interventions). Given the possibility that other aspects of
study design may have been confounded with the therapeutic orientation of the
interventions included in the different studies, our results regarding the superiority of IPT
to CBT should be interpreted with caution. Further research evaluating the efficacy of
well-defined cognitive-behavioral interventions for this population, particularly trials in
which faithfully administered CBT and IPT protocols are compared directly to one
another, is necessary to establish whether IPT is truly a more effective intervention for
perinatal depression. Such studies would be greatly beneficial given the low acceptability
of antidepressant medication in this population and preference for non-pharmacologic
treatments, including psychotherapy (Kim et al., 2011).
Another important moderator identified in these analyses is the superiority of
individually-administered therapeutic interventions to those conducted in a group format.
Uncontrolled effect sizes were larger for studies in which therapy was conducted on an
individual basis; a comparable pattern was observed for controlled effect sizes, although
this difference did not reach significance due to the smaller number of included studies.
There has been great interest in the potential use of group treatments for perinatal
depression, and some have suggested that the format may be particularly well-suited for
this population because it provides an opportunity for normalizing women’s experiences
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and decreasing social isolation (Mulcahy, Reay, Wilkinson, & Owen, 2009). The results
of these analyses suggest that these benefits may not be sufficient to lead to a reduction in
depressive symptoms comparable to that which can be achieved through individual
psychotherapy.
Our results suggest that further assessment of home-based interventions is
necessary in order to determine the efficacy of these programs. There was a trend for
depressive symptoms to decrease more over time in studies that incorporated home-based
interventions; however, there was also a trend for greater effects in studies that
incorporated clinic-based interventions with respect to the superiority of treated groups to
control conditions. Both of these results should be interpreted with caution, as only two
studies of home-based interventions were included in these moderator analyses. Further
research, ideally trials in which comparable interventions administered either in a clinic
or home setting can be directly compared, is necessary to determine whether the location
in which therapy is conducted effects the efficacy of these interventions.
There was a trend for longer treatments to have larger uncontrolled effect sizes,
but treatment length was not associated with controlled effect sizes. As uncontrolled
effect sizes do not distinguish between the effects of interventions and decreases in
symptoms over time, this raises the concern that the apparent effects of treatment may
simply reflect a natural decrease in symptoms over time. There is evidence that, for most
women, high levels of depressive symptoms naturally remit over the perinatal period
(Heron, O’Connor, Evans, Golding, & Glover, 2004). One study included in these
analyses found that three active treatment groups were only superior to routine primary
care at 4.5 months postpartum; by 9 months postpartum the depressive symptoms of the
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control group had declined to levels comparable to those observed in the treated groups,
and differences among the groups remained nonsignificant through five years postpartum
(Cooper, Murray, Wilson & Romaniuk, 2003). However, other included studies found
that treatment groups continued to be superior to control groups at follow-up times
ranging from 3-6 months posttreatment (Grote et al., 2009; Honey, Bennett & Morgan,
2002; Mulcahy, Reay, Wilkinson & Owen, 2009).
Unfortunately, the number of studies that have included follow-up assessments of
treated subjects is too small for a meta-analysis of long-term outcomes. Five studies in
which an intervention was compared to a control group reported follow-up outcomes,
with the timing of follow-up assessments ranging from 3 months to 5 years posttreatment.
An initial analysis suggested that the treated group remained superior at the first
posttreatment follow-up assessment (which ranged from 3 to 6 months posttreatment),
with a positive effect size in the moderate range. However, the SAMD values indicated
that two studies were significant outliers, and the fail-safe N for this analysis indicated
that the number of studies with null results necessary to reduce the effect size to zero was
below the tolerance limit. Further assessment of long-term outcomes for subjects in
controlled trials of interventions for perinatal depression are necessary to assess whether
the benefits of treatment for perinatal depression are maintained over time.
The present meta-analysis has several limitations. Reflecting the status of the
field, the number of included studies is relatively small, particularly for the analysis of
controlled effect sizes. Moderator analyses were likewise limited by the small number of
included studies. The quality of studies assessing interventions among this population is
somewhat limited (see also Cuijpers, Brännmark, & van Straten, 2008; Dennis, 2004). Of
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particular concern is the fact that 8 studies of psychological interventions did not exclude
subjects who were receiving pharmacological treatment, and rates of concurrent
antidepressant use were quite high in some of these studies. As this raises the possibility
that the purported effects of psychotherapy in these studies could have been the result of
pharmacological interventions, future research is necessary both to establish the separate
effects of psychotherapy and pharmacotherapy (by excluding subjects receiving
concurrent treatment from research) and to explicitly assess the efficacy of combined
psychological and pharmacological treatments. Compared with psychological
interventions, there has been relatively little assessment of the efficacy of antidepressant
medication in this population. Of the seven studies that included antidepressant treatment,
three were open trials and two compared a combined treatment to either psychological or
pharmacological monotherapy. Given the ethical concerns regarding the use of notreatment control groups in treatment studies with this population, further studies in
which pharmacological treatments are directly compared to psychological or combined
interventions are necessary to address the relative efficacy of these interventions. Barber
(2009) also suggested that there is room for large scale, relatively well controlled,
naturalistic studies for examining the efficacy of psychotherapy, as the field does not
have the resources to conduct all the RCTs that need to be conducted. Finally, because
psychotherapies are large packages, research that focuses on specific interventions from a
package could be used to determine which specific interventions are particularly useful
(e.g., Barber et al., 1996, DeRubeis & Feeley, 1990; Webb, DeRubeis, & Barber, 2010).
In summary, these meta-analyses demonstrated that a range of interventions are
effective in the reduction of perinatal depressive symptoms. Reductions in symptoms
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from prettest to posttreatment are large, and symptom levels at posttreatment are below
cutoffs for clinically significant symptoms. These interventions reliably lead to moderate
reductions in depressive symptoms compared to control groups. Interestingly, there was
initial evidence that IPT may be more effective than CBT, although further research is
necessary to establish whether this can be attributed to methodological differences
between studies assessing the two forms of psychotherapy. Relatively few studies of
antidepressant medication for this population have been conducted compared to
psychological interventions, and overall most interventions have not been assessed in
comparison to control or other active treatment conditions. Given the prevalence of
perinatal depression and the negative outcomes associated with depressive symptoms
during this period, the identification of effective and acceptable treatments for this
population is vitally necessary. Although more research is needed to confirm and extend
the results of these meta-analyses, these results suggest a range of interventions for
further investigation as treatments for this disorder.
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Table 1
Characteristics of Studies Assessing Interventions for Perinatal Depression
Study
Appleby et al.
(1997)
Chabrol et al.
(2002)
Clark et al.
(2003)
Cohen et al.
(2001)
Cooper et al.
(2003)
Craig et al.
(2005)
Freeman et al.
(2008)
Grote et al.
(2009)
Honey et al.
(2002)
Klier et al.
(2001)
Meager & Milgrom
(1996)
Milgrom et al.
(2005)
Miller et al.
(2008)
Misri et al.
(2004)
Mulcahy et al.
(2009)
O'Hara et al.
(2000)
Pearlstein et al.
(2006)
Prendergast & Austin
(2001)

Country

N

Study
Design

UK

87

RCT

FR

48

RCT

US

39

QRT

US

15

OT

UK

193

RCT

AUS

16

OT

Control
Type

Population

Intervention

Dx

Measure

Tx
Length

%
Attrition

Treatment

Format

Admin

POST

COMB

Y

EPDS

12

30

CBT

IND

CLIN

TAU

POST

THER

Y

EPDS

12

0

CBT

IND

HOME

WL

POST

THER

Y

BDI

12

10

M-ITG + IPT

COMB

CLIN

POST

MED

Y

HDRS

8

33

Venlafaxine

POST

THER

Y

EPDS

10

17

CBT + NDC +
PDT

IND

HOME

POST

THER

N

EPDS

9

13

CBT

GRP

CLIN

IND

CLIN

TAU

MIXED

COMB

Y

EPDS

8

34

SUPP + Omega-3
Fatty Acids

TAU+

ANTE

THER

Y

EPDS

NS

13

IPT

IND

CLIN

TAU

POST

THER

N

EPDS

8

9

PEG

GRP

CLIN

POST

THER

Y

EPDS

12

35

IPT

GRP

CLIN

WL

POST

THER

N

EPDS

10

40

CBT

GRP

CLIN

TAU

POST

THER

Y

BDI

12

37

CBT + NDC

COMB

CLIN

OT

ANTE

THER

Y

EPDS

12

0

IPT

GRP

SCHOOL

35

RCT

POST

COMB

Y

EPDS

12

9

CBT

IND

CLIN

AUS

50

RCT

TAU

POST

THER

Y

EPDS

8

15

IPT

GRP

CLIN

US

99

RCT

WL

POST

THER

Y

HDRS

12

18

IPT

IND

CLIN

US

23

QRT

POST

COMB

Y

EPDS

12

22

IPT

IND

CLIN

AUS

37

RCT

POST

THER

Y

EPDS

6

0

CBT

IND

HOME

US

59

RCT

US

53

RCT

UK

45

RCT

AUST

17

OT

AUS

20

RCT

AUS

120

RCT

US

11

CAN

TAU+
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Study
Design

Control
Type

Tx
Length

%
Attrition

Study
Country
N
Population Intervention Dx Measure
Treatment
Format
Admin
Reay et al.
AUS
18
OT
POST
THER
Y
EPDS
8
6
IPT
GRP
CLIN
(2006)
Spinelli
US
13
OT
ANTE
THER
Y
EPDS
16
31
IPT
IND
CLIN
(1997)
Spinelli & Endicott
US
50
RCT
ACT
ANTE
THER
Y
EPDS
16
24
IPT
IND
CLIN
(2003)
Stowe et al.
US
26
OT
POST
MED
Y
BDI
8
19
Sertraline
(1995)
Stuart & O'Hara
US
12
OT
POST
THER
Y
HDRS
NS
42
IPT
IND
CLIN
(1995)
Suri, Burt, & Altshuler
US
4
OT
POST
MED
Y
HDRS
8
25
Nefazodone
(2005)
Wickberg & Hwang
SWE
48
RCT
TAU
POST
THER
N
MADRS
6
15
NDC
IND
COMB
(1996)
Wiklund, Mohlkert, & Edman
SWE
66
RCT
TAU
POST
THER
N
EPDS
7
0
CBT
IND
CLIN
(2010)
Yonkers et al.
US
70
RCT
PLA
POST
MED
Y
HDRS
8
56
Paroxetine
(2008)
Note. Dx = required clinician-administered diagnostic assessment, Tx Length = treatment length in weeks, Admin = Location of therapy administration, AUS = Australia, AUST = Austria, CAN =
Canada, FR = France, SWE = Sweden, UK = United Kingdom, US = United States, OT = open trial, QRT = quasi-randomized trial, RCT = randomized controlled trial, TAU = treatment as usual, TAU+
= enhanced treatment as usual, WL = waiting list, ACT = active control, PLA = placebo, ANTE = antepartum, POST = postpartum, MIXED = antepartum + postpartum, MED = antidepressant
medication, COMB = combined antidepressant medication + psychotherapy, THER = psychotherapy, BDI = Beck Depression Inventory, EPDS = Edinburgh Postnatal Depression Scale, HDRS =
Hamilton Depression Rating Scale, MADRS = Montgomery-Asberg Depression Rating Scale, CBT = cognitive-behavioral therapy, IPT = interpersonal psychotherapy, M-ITG = mother-infant therapy
group, NDC = nondirective counseling, PEG = psychoeducational group, PDT = psychodynamic therapy, SUPP = manualized supportive psychotherapy, COMB = combined individually + group
administered, IND = individually-administered, GRP = group-administered, CLIN = clinic-based intervention, COMB = combined clinic- + home-based intervention, HOME = home-based intervention,
SCHOOL = school-based intervention
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Table 2
Methodological Quality of Studies Assessing Interventions for Perinatal Depression
RCTs
Study
Open Trials
Cohen et al.
(2001)
Craig, Judd, & Hodgins
(2005)
Klier et al.
(2001)
Miller et al.
(2008)
Reay et al.
(2006 US)
Spinelli,
(1997)
Stowe et al.
(1995)
Stuart & O'Hara
(1995)
Suri, Burt, & Altshuler
(2005)
Quasi-Randomized Trials
Clark, Tluczek, & Wenzel
(2003)
Pearlstein et al.
(2006)
Randomized Controlled Trials
Appleby et al.
(1997)
Chabrol et al.
(2002)

Psychological Interventions

ITT

Char
Sample

Concurr
Tx

Blind
Assess

+

+

NS

NS

−

−

NS

NS

+

+

+

−

−

+

+

Y

−

+

+

+

−

−

+

+

N

+

+

+

−

−

−

+

+

Y

+

+

+

+

+

+

+

+

NS

NS

−

−

−

−

−

−

+

NS

−

−

+

Y

NS

−

−

NS

+

−

+

Y

NS

+

+

+

+

−

−

+

N

NS

+

−

+

+

+

+

NS

+

+

+

−

+

+

N

−

−

+

+

Random

Spec Ther

−

Manual

Trng

−

−

Super

Adher

Pharmacologic
Interventions
Blind
Clinic
Blind Pt
−

−

−

−

−

−

−

−

−

−

+

+

+

+

+

−

−
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RCTs

Psychological Interventions

Pharmacologic
Interventions
Blind
Clinic
Blind Pt

Char
Concurr
Blind
Sample
Tx
Assess
Study
ITT
Random
Spec Ther
Manual
Trng
Super
Adher
Cooper et al.
+
+
NS
+
−
+
+
+
+
(2003)
Freeman et al.
+
+
N
NS
−
−
+
−
−
+
+
(2008)
Grote et al.
+
+
N
NS
+
+
+
+
+
(2009)
Honey et al.
+
+
Y
NA
+
+
−
−
−
(2002)
Meager & Milgrom
−
+
Y
NA
−
+
−
−
−
(1996)
Milgrom et al.
+
+
N
NA
−
+
+
+
+
(2005)
Misri et al.
+
+
N
−
+
+
+
−
−
−
−
(2004)
Mulcahy et al.
+
+
Y
+
+
+
+
+
+
(2009)
O'Hara et al.
+
+
NS
−
+
+
+
+
+
(2000)
Prendergast & Austin
+
+
Y
NS
+
+
+
+
+
(2001)
Spinelli, & Endicott
+
+
N
NS
+
+
+
+
+
(2003)
Wickberg & Hwang
−
+
N
+
+
+
−
+
+
(1996)
Wiklund, Mohlkert, &
+
+
Y
NA
+
+
−
−
−
Edman (2010)
Yonkers et al.
+
+
N
+
+
+
+
(2008)
Note. ITT = report intent-to-treat analyses, Char Sample = specify characteristics of sample, Concurr. Tx = subjects allowed to receive concurrent antidepressant or psychological treatment, Blind
Assess. = clinician-administered diagnostic measures conducted by independent evaluator blind to treatment condition, Random. = specification of method of randomization, Spec. Ther. = specify
therapist characteristics, Manual = specify use of therapy manual, Trng = describe therapist training, Super. = describe therapist supervision, Adher. = indicate therapy was assessed for adherence to
model, Blind Clinic. = clinician blind to treatment status, Blind Pt. = patient blind to treatment status, + = yes, − = no, NA = not applicable, NS = not specified, Y = yes, N = no
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Table 3
Random Weighted Uncontrolled Effect Sizes from Studies Assessing Interventions
for Perinatal Depression
Study
Appleby et al. (1997)
Chabrol et al. (2002)
Clark, Tluczek, & Wenzel (2003)
Cohen et al. (2001)
Craig, Judd, & Hodgins (2005)
Freeman et al. (2008)
Grote et al. (2009)
Honey et al. (2002)
Klier et al. (2001)
Meager & Milgrom (1996)
Miller et al. (2008)
Misri et al. (2004)
Mulcahy et al. (2009)
O'Hara et al. (2000)
Pearlstein et al. (2006)
Prendergast & Austin (2001)
Reay et al. (2006)
Spinelli, & Endicott (2003)
Spinelli, (1997)
Stowe et al. (1995)
Stuart & O'Hara (1995)
Suri, Burt, & Altshuler (2005)
Wickberg & Hwang (1996)
Wicklund, Mohlkert, & Edman (2010)
Yonkers et al. (2008)
Total (all studies)
Total (outlier excluded)
Total (trim-and-fill correction)
* p < 0.05, ** p < 0.01, *** p < 0.001
1
Outlier excluded from subsequent analyses.

n
87
18
24
15
14
51
25
23
17
6
11
35
23
48
23
17
18
21
13
19
6
3
20
66
17
k
25
24

Hedges’ g
4.39***
1.92***
1.03***
1.68***
1.44***
1.29***
3.00***
0.78***
1.35***
0.95*
0.91***
1.72***
1.56***
2.05***
2.66***
2.60***
1.61***
1.20***
1.28***
1.20***
1.39***
1.67***
0.83***
2.03***
1.42***
Hedges’ g
1.66***
1.54***
1.61

SAMD
10.701
0.46
-1.30
0.03
-0.33
-1.12
2.82
-1.76
-0.52
-0.59
-0.98
0.17
-0.20
1.15
2.02
1.61
-0.09
-0.88
-0.55
-0.83
-0.23
0.00
-1.53
-0.40
0.92
95% CI
1.41-1.91
1.34-1.73
1.40-1.81

Q(df)
280.99(24)***
159.22(23)***
199.09

I2
91.46
85.56
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Table 4
Analyses of Moderation for Uncontrolled Effect Sizes
Moderator
Study Design
Open Trial
Quasi-Randomized Trial
RCT
Population
Antepartum
Postpartum
Clinician-Verified Diagnosis
Yes
No
Measure
BDI
EPDS
HDRS
Intervention Type
Combination
Medication
Therapy
Therapy Type
Group
Individual
Therapy Location
Clinic
Home
CBT/IPT vs. Other Psychological
CBT/IPT
Other
CBT vs. Other Psychological
CBT
Other
IPT vs. Other Psychological
IPT
Other
CBT vs. IPT
CBT
IPT
* p < 0.05, ** p < 0.01, *** p < 0.001

n

Hedges’ g

95% CI

9
2
13

1.39***
1.81*
1.62***

1.22-1.56
0.22-3.41
1.32-1.92

4
19

1.57***
1.55***

0.76-2.38
1.33-1.77

19
5

1.61***
1.22***

1.40-1.82
0.69-1.75

2
16
5

1.10***
1.62***
1.65***

0.94-1.27
1.34-1.89
1.35-1.95

3
4
17

1.83***
1.46***
1.51***

1.17-2.49
1.22-1.69
1.22-1.79

7
12

1.23***
1.79***

0.95-1.51
1.48-2.10

16
2

1.64***
2.33***

1.36-1.92
1.63-3.03

18
2

1.61***
1.11***

1.34-1.89
0.67-1.54

7
13

1.63***
1.52***

1.16-2.10
1.21-1.83

11
9

1.61***
1.49***

1.25-1.97
1.13-1.85

7
11

1.63***
1.61***

1.16-2.10
1.25-1.97

Q(df)
1.86(2)

p
0.39

0.003(1)

0.96

1.82(1)

0.18

15.44(2)

0.000***

1.09(2)

0.58

6.93(1)

0.008**

3.16(1)

0.08

3.72(1)

0.05*

0.14(1)

0.71

0.23(1)

0.64

0.003(1)

0.95
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Table 5
Random Weighted Controlled Effect Sizes from Studies Comparing Interventions
for Perinatal Depression to Control Conditions
Study
Chabrol et al. (2002)
Clark, Tluczek & Wenzel (2003)
Cooper et al. (2003)
Grote et al. (2009)
Honey, Bennett & Morgan (2002)
Meager & Milgrom (1996)
Milgrom et al. (2005)
Mulcahy et al. (2009)
O'Hara et al. (2000)
Prendergast & Austin (2001)
Spinelli & Endicott (2003)
Wickberg & Hwang (1996)
Wiklund, Mohlkert, & Edman (2010)
Yonkers et al. (2008)
Total
Total (excluding outlier)
* p < 0.05, ** p < 0.01, *** p < 0.001
1
Outlier excluded from subsequent analyses.

n
48
35
184
53
45
12
192
50
99
37
38
41
33
31
k
14
13

Hedges’ g
2.33***
0.46
0.39*
1.35***
0.36
0.97
0.31
0.63*
1.19***
0.31
0.96**
0.81*
0.51*
0.60
Hedges’ g
0.76***
0.65***

SAMD
5.381
-0.89
-2.42
2.14
-1.35
0.31
-2.95
-0.47
2.13
-1.35
0.57
0.14
-0.73
-0.44
95% CI
0.50-1.03
0.45-0.86

Q(df)
40.75(13)***
21.12(12)*

I2
68.10
43.19
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Table 6
Analyses of Moderation for Controlled Effect Sizes
Moderator
Control Type
TAU
TAU+
Wait List
Population
Antepartum
Postpartum
Clinician-Verified Diagnosis
Yes
No
Measure
BDI
EPDS
HDRS
Therapy Type
Combined
Group
Individual
Therapy Location
Clinic
Home
CBT vs. IPT
CBT
IPT
* p < 0.05, ** p < 0.01, *** p < 0.001

n

Hedges’ g

95% CI

6
2
3

0.45***
0.84
0.93***

0.27-0.63
-2.04
0.45-1.41

2
11

1.18***
0.57***

0.74-1.62
0.38-0.75

10
3

0.65***
0.66***

0.40-0.90
0.30-1.02

2
8
2

0.35*
0.63***
0.97***

0.02-0.68
0.38-0.87
0.41-1.53

2
3
7

0.35*
0.55**
0.78***

0.02-0.68
0.17-0.93
0.46-1.09

9
2

0.73***
0.38*

0.45-1.00
0.09-0.67

6
5

0.40***
0.96***

0.21-0.59
0.64-1.28

Q(df)
3.72(2)

p
0.16

6.24(1)

0.01*

0.003(1)

0.96

3.87(2)

0.14

3.41(2)

0.18

2.96(1)

0.09

8.81(1)

0.003**

Included

Eligibility

Screening

Identification
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Records identified through
database searching & reference
review
(n = 1548)

Records after duplicates removed
(n = 1447)

Full-text articles assessed for
eligibility
(n = 152)

Studies
included in
meta-analysis
(controlled
ES):
(n = 14)

Studies
included in
meta-analysis
(uncontrolled
ES):
(n = 25)

Full-text articles excluded:

Prevention Trials (n = 30)
No Trial (n = 10)
Study Design (n = 14)
Population (n = 7)
Intervention (n = 47)
Insufficient Data (n = 8)
Qualitative Data (n = 3)
Secondary Analyses (n = 3)

Figure 1. Flow chart illustrating the identification of included studies
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Chapter 3:
Preventing Postpartum Depression: A Meta-Analytic Review
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Abstract
This meta-analysis assessed the efficacy of a wide range of preventive interventions
designed to reduce the severity of postpartum depressive symptoms or decrease the
prevalence of postpartum depressive episodes. A systematic review identified 37
randomized or quasi-randomized controlled trials in which an intervention was compared
to a control condition. Differences between treatment and control conditions in the level
of depressive symptoms and prevalence of depressive episodes at 6 months postpartum
were assessed in separate analyses. Depressive symptoms were significantly lower at
post-treatment in intervention conditions as compared to control conditions, with an
overall effect size in the small range after exclusion of outliers (Hedges’ g = 0.18). There
was a 27% reduction in the prevalence of depressive episodes in intervention conditions
compared to control conditions at 6 months postpartum, OR = 0.73, after removal of
outliers and correction for publication bias. Later timing of postpartum assessments was
associated with smaller differences between intervention and control conditions in both
analyses. Among studies that assessed depressive symptoms using the EPDS, higher
levels of depressive symptoms at pre-treatment were associated with smaller differences
in depressive symptoms between treatment and control conditions at 6 months
postpartum. No other moderators were identified in either analysis. These findings
suggest that interventions designed to prevent postpartum depression effectively reduce
levels of postpartum depressive symptoms and decrease risk for postpartum depressive
episodes.
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Preventing Postpartum Depression: A Meta-Analytic Review
While the goal of treatment is to alleviate symptoms among individuals
experiencing a given disorder, preventive interventions are intended to avoid the initial
onset of disorder. Emotional and behavioral difficulties are commonly identified and
treated only after the onset of illness, but prevention of these disorders can significantly
reduce the human and economic costs associated with mental illness (National Research
Council & Institute of Medicine, 2009). A recent review of progress that has been made
in the field of depression prevention identified the implementation of interventions with
strong evidence of effectiveness as a major goal for ongoing research in this area
(Muñoz, Beardslee, & Leykin, 2012). In order for this goal to be reached, it is necessary
to identify characteristics of effective preventive interventions.
Postpartum depression is a specific mental disorder for which preventive
interventions could yield dramatic benefits. Depression is one of the most common
complications of childbearing; a meta-analytic review found that approximately 13% of
women will experience a major depressive episode during the first postpartum year
(O’Hara & Swain, 1996). According to the World Health Organization, depression is the
leading cause of disability worldwide (WHO, 2012). Children of mothers with
postpartum depression are at increased risk for long-term cognitive impairment,
emotional difficulties, and behavioral problems (Grace, Evindar, & Stuart, 2003).
The context in which postpartum depression occurs provides unique opportunities
for preventive interventions. Women with fewer financial resources may have greater
access to healthcare during pregnancy than during other points in the lifespan; for
example, in the United States, women are eligible for Medicaid during pregnancy and the
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first 60 days postpartum (Centers for Medicare and Medicaid Services, 2012). More
generally, pregnancy is a time of increased healthcare utilization, which provides
opportunities for screening and intervention. Research has identified demographic groups
at high risk for postpartum depression, such as minority women and women of low
socioeconomic status, which may be used to target women at increased risk for the
disorder (Beck, 1996; O’Hara & Swain, 1996). Finally, there is some evidence that
preventive interventions may be more acceptable, particularly among African-American
women, than treatment for depression (Crockett, Zlotnick, Davis, Payne & Washington,
2008).
A wide range of interventions for preventing postpartum depression have been
assessed in randomized controlled trials. Many preventive interventions have modified
treatments demonstrated to be effective for postpartum depression. For example,
psychotherapy – particularly cognitive-behavioral and interpersonal psychotherapy – and
antidepressant medication have all been shown to be effective in the treatment of
postpartum depression (Sockol, Epperson, & Barber, 2011). Some studies have assessed
whether implementation of these interventions before the onset of a depressive episode
can effectively prevent the disorder (e.g., Austin et al., 2008; Wisner, Perel, Peindl,
Hanusa, Findling & Rapport, 2001; Zlotnick, Capezza, & Parker, 2011). Non-therapeutic
social support and educational interventions have also been assessed as preventive
interventions (e.g., Dennis et al., 2009). Other research has investigated whether
modifications to standard postpartum care, such as having women attend their first
postpartum checkup at 1 week instead of 6 weeks postpartum, can reduce the incidence
of depression after childbirth (Gunn, Lumley, Chondros & Young, 1998). Alternative
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approaches to treatment, notably dietary supplements and hormonal interventions, have
also been assessed as potential preventive interventions for postpartum depression (e.g.,
Lawrie, Hofmeyr, De Jager, Berk, Paiker & Viljoen, 1998; Llorente, Jensen, Voigt,
Fraley, Berretta & Heird, 2003). Given the wide range of approaches that have been
utilized in prevention research, a comprehensive review of the research in this area is
needed to provide clinicians and researchers with important information regarding the
absolute and relative efficacy of these interventions.
While a great number of reviews of the literature on the prevention of postpartum
depression have been published, most of these reviews are qualitative in nature (e.g.,
Boath, Bradley, & Henshaw, 2005; Dennis, 2004a; Dennis, 2004b). Several quantitative
systematic reviews have attempted to synthesize prior findings in this area. Lumley,
Austin, and Mitchell (2004) reviewed studies initiated during pregnancy and the
postpartum period; their meta-analysis found that only indicated postnatal interventions
were associated with decreased risk for postpartum depression. This meta-analysis did
not assess possible moderators of effect sizes. In another quantitative review, Dennis
(2005) conducted a meta-analysis of 15 psychological and psychosocial interventions for
preventing postpartum depression. These analyses found that prevention programs did
not significantly reduce risk for postpartum depression. However, analyses of moderators
suggested that interventions were more effective when they targeted women at increased
risk, when they included a postnatal component, and when they were administered
individually. In their review of hormonal interventions for preventing and treating
postpartum depression, Dennis, Ross, and Herxheimer (2009) identified only one study in
which hormones were utilized as a preventive intervention. Similarly, a review of
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antidepressant prevention of postnatal depression identified only two studies in which
medication was utilized for prevention, rather than treatment, of postpartum depression
(Howard, Hoffbrand, Henshaw, Boath, & Bradley, 2009). A protocol for a review of
dietary supplements for preventing postpartum depression has been published, but the
review has yet to be conducted (Miller, Murray, Beckmann, Kent, & Macfarlane, 2011).
Overall, existing meta-analyses suggest that preventive interventions for
postpartum depression may have limited efficacy. However, these analyses have several
limitations. Each of these analyses was limited to a single type of intervention (e.g.,
psychosocial, hormonal, pharmacological), which precludes the comparison of these
approaches. With the exception of the Dennis (2005) meta-analysis, these studies have
not assessed elements of study design or interventions as potential moderators of the
efficacy of these interventions. These studies also fail to specify the timing of the
postpartum assessments that were used to calculate the effect sizes. A meta-analytic
review of depression during the perinatal period found that the prevalence of this disorder
decreases after seven months postpartum, which suggests that the timing of evaluation
should be considered when evaluating the efficacy of prevention programs (Gavin,
Gayner, Lohr, Meltzer-Brody, Gartlehner, & Swinson, 2005).
The present meta-analysis addresses several limitations of the above studies. We
included a wide range of interventions, which allows for the direct comparison of the
efficacy of different approaches. We included interventions other than antidepressant
medication and psychotherapy, as there is evidence that women may prefer alternative
treatments during pregnancy and the postpartum period (Uebelacker, Epstein-Lubow,
Gaudiano, Tremont, Battle, & Miller, 2010). In order to assess whether these alternative
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interventions are as effective as empirically supported treatments, we elected to include
as wide a range of preventive interventions as was possible. We limited our analyses to
those in which postpartum depression was assessed within the first 6 months postpartum.
We assessed characteristics of included studies and interventions as potential moderators
of effect size. We also included several studies that have been published since earlier
meta-analyses were conducted. The goal of the current meta-analysis was to assess the
efficacy of a range of preventive interventions for postpartum depression. We assessed
both the level of depressive symptoms in treatment conditions compared to control
conditions and the difference in the prevalence of depressive episodes at six months
postpartum.
Method
Search Procedures and Selection of Studies
Relevant studies were identified through searches of PsycInfo and PubMed
through April 2012 using postpartum depression and prevention as keyword search
terms. The reference lists of existing meta-analyses, relevant reviews, chapters, and
retrieved articles were inspected for further relevant studies. Clinical trial databases
(including the Cochrane Pregnancy and Childbirth Group, Cochrane Depression, Anxiety
and Neurosis Group, and the International Standard Randomised Controlled Trial
Number Register) were also reviewed for eligible studies.
To be included in the meta-analysis, studies had to meet the following inclusion
criteria:
(a) Study design included intervention and control group(s). Both randomized and quasirandomized controlled trials were eligible for inclusion.
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(b) Authors specified that the goal of the intervention was to reduce postpartum
depressive symptoms and/or the prevalence of postpartum major depressive episodes.
Interventions that did not explicitly target depressive symptoms, such as smoking
cessation programs, were excluded, even if authors reported outcome data for
depressive symptoms and/or major depressive episodes. Interventions in which
maternal depression was not the primary outcome of interest, such as studies of infant
development, were excluded. Interventions designed to treat postpartum depression
were excluded. Interventions were classified as treatment studies if all subjects met
criteria for a major depressive episode at pre-treatment or if all subjects had
depressive symptoms above a cutoff indicative of clinically significant depressive
symptoms at pre-treatment.
(c) Intervention was initiated during pregnancy or within 4 weeks of childbirth.
(d) Reported outcomes for depressive symptoms and/or prevalence of depressive
episodes between 1 and 6 months postpartum using a validated self-report or
clinician-administered measure.
(e) Reported sufficient outcomes to allow for the calculation effect size(s).
A flow chart summarizing the search process and exclusion of studies is presented
in Figure 1. After removal of duplicates, the search procedure yielded 797 studies, of
which 117 studies were obtained and reviewed for inclusion. Of these 117 studies, 80
were excluded for the following reasons: 17 studies were excluded because the target
outcome of the intervention was not depressive symptoms or depression diagnosis, 16
were excluded because they were not randomized or quasi-randomized controlled trials,
14 studies were excluded because they did not report outcome data or reported
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insufficient data for the calculation of effect sizes, 11 were excluded because the
intervention was initiated after 4 weeks postpartum, 5 were excluded because they did not
include a postpartum assessment between 1 and 6 months postpartum, 4 were excluded
because they were treatment studies in which subjects were selected on the basis of
depressive symptoms and/or diagnosis, and 1 was excluded because the measure of
depressive symptoms was not validated. Secondary manuscripts were identified for 12
studies; all original manuscripts provided sufficient information for coding and
calculation of effect sizes so these were not utilized. The remaining 37 articles were
eligible for inclusion in the meta-analysis. Twenty-four studies reported sufficient
outcome measures for calculation of effect sizes representing the difference in depressive
symptoms between treatment and control conditions at 6 months postpartum, and 28
studies reported sufficient outcome measures for calculation of effect sizes representing
the difference in prevalence of depressive episodes at 6 months postpartum.
Coding of Studies
All studies were coded for intervention type (dietary supplement vs. educational
vs. hormonal vs. medication vs. modified care vs. therapy vs. social support).
Interventions were classified as educational when the intervention consisted of providing
information, either verbal or written, regarding postpartum depression and accessing
treatment without actively engaging participants in activities designed to change behavior
or mood. Interventions were coded as therapy when they were clinician-led and
participants were engaged in activities with a goal of modifying behavior, cognition, or
mood. Interventions in which participants were provided with nonspecific support were
coded as social support interventions. For moderator analyses, interventions were also
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coded as biological interventions (dietary supplement, hormonal, and medication) or
psychosocial interventions (educational, modified care, therapy, and social support) and
as established treatments for postpartum depression (cognitive-behavioral therapy,
interpersonal psychotherapy, and antidepressant medication) and non-established
treatments for postpartum depression (dietary supplements, educational interventions,
hormonal interventions, modified care, other psychotherapies, and social support).
Studies were also coded for type of control group (active vs. educational vs.
placebo vs. treatment-as-usual), timing of intervention (pregnancy vs. labor vs.
postpartum), outcome measure, and timing of postpartum assessment (in weeks). The
type of prevention study was classified using the criteria proposed by the Institute of
Medicine report on prevention research (Mrazek & Haggerty, 1994): indicated
interventions target individuals with subclinical symptoms who do not meet diagnostic
criteria, selected interventions target individuals with risk factors for a disorder but
without symptoms of the disorder, and universal interventions are administered to all
members of a given population. While a conservative definition of preventive
interventions would have required us to exclude studies in which subjects were
experiencing major depressive episodes at pre-treatment, over a third of the potential
studies either did not assess for the presence of a major depressive episode at pretreatment or did not exclude subjects on the basis of a positive screening. Given the large
number of studies that would have been excluded on the basis of this criterion, we elected
to include these studies and to assess this as a potential moderator of effect size (excluded
subjects with MDE at pre-treatment vs. did not assess/did not exclude subjects with MDE
at pre-treatment). We also coded the average level of depressive symptoms at pre-
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treatment across treatment and control conditions.
Because studies did not consistently report sample characteristics (ethnicity,
parity, and marital status), these variables were not coded.
The only intervention type for which enough studies were included to assess
potential moderators of effect size was therapeutic interventions. These studies were also
coded for therapeutic orientation (cognitive-behavioral therapy vs. eclectic vs.
interpersonal psychotherapy), whether therapy was conducted individually or in a group
format, and the number of therapy sessions.
Effect sizes were calculated using the study’s designated primary outcome
measure. When more than one postpartum assessment was conducted between 1 and 6
months postpartum, the latest assessment point was used.
Analyses
Two separate analyses were conducted. The first analysis compared the difference
in depressive symptoms at 6 months postpartum between treatment and control
conditions using the standardized mean group difference. While this effect size does not
account for possible differences in depressive symptoms between treatment and control
conditions at pre-treatment, too few studies reported pre-treatment depressive symptoms
for effect sizes that take these potential differences into account to be calculated. Effect
sizes were calculated by dividing the difference between treatment and control means by
the pooled standard deviation, corrected for upward bias using Hedges’ g (Hedges, 1981):

[
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where the pooled standard deviation is defined as
√

)

)
)

and cm is defined as
)
Effect sizes were calculated so that positive effect sizes represent lower scores in the
intervention group compared to the control group.
The second analysis compared the prevalence of depressive episodes at 6 months
postpartum between treatment and control conditions using the odds ratio:
)
)
Where PT is the proportion of depressed subjects in treatment conditions and PC is the
proportion of depressed subjects in treatment conditions. Odds ratios less than 1 indicate
lower rates of depression among treated conditions compared to control conditions.
The heterogeneity of effect sizes was examined using the Q statistic and the I2
index. Significant Q statistics indicate that the observed range of effect sizes is
significantly larger than would be expected based on within-study variance. The I2 value
indicates the proportion of variance in effect sizes accounted for by between-study
variance. The index has a range from 0 to 100; Higgins and colleagues (2003) suggest
that 25, 50 and 75% I2 values indicate low, medium and high levels of hetereogeneity,
respectively. When analyses indicated significant heterogeneity among effect sizes,
exploratory analyses were conducted to assess for moderators of effect size. Categorical
moderators were assessed using an analysis of variance (ANOVA) of mixed-effects
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models for each variable hypothesized to influence the effect size. Meta-regression
analyses were conducted to assess the effects of continuous moderators.
Publication bias was assessed by visual examination of funnel plots, Duval and
Tweedie’s (2000) trim-and-fill procedure, and classic fail-safe N values (Rosenthal,
1979). First, the effect size for each study was plotted against the study standard error. An
asymmetric distribution suggests missing studies due to publication bias (Lipsey &
Wilson, 2001). We used Duval and Tweedie’s trim-and-fill procedure (2000) to identify
asymmetric distributions of effect sizes. When this test indicated significant asymmetry
in the funnel plot, the overall estimates for the model were calculated using the trim-andfill correction (Duval & Tweedie, 2000). Using the fail-safe N value, we determined the
number of studies with null findings that would be necessary to produce a nonsignificant
overall effect size. Using Rosenthal’s (1991) recommendation, a value of 5K + 10, where
K is the number of observed studies, was used as the cutoff for an unlikely number of
studies.
For each of these analyses, outliers were identified using the sample-adjusted
meta-analytic deviance (SAMD) statistic (Huffcutt & Arthur, 1995). A conservative
cutoff score of 2.58 was used to consider studies for exclusion from the analyses, since
extreme values can result from either true population variability or error, and removing
outliers whose effects represent true variability limits the ability to assess the role of
moderators (Beal, Corey & Dunlap, 2002). The SAMDs were rank-ordered and the scree
plots examined to confirm the outlier status of studies with SAMDs above this cutoff. In
cases where the SAMD value was greater than 2.58 but the scree plot suggested that the
SAMD was not discrepant from the overall distribution, the study was retained to
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maximize the variance available to assess the role of moderators.
Calculations of weighted mean effect sizes, heterogeneity, and moderators were
conducted using Comprehensive Meta-Analysis, version 2.2.046 (Borenstein, Hedges,
Higgins, & Rothstein, 2005). We estimated overall effect sizes using random effects
models, based on the assumption that the included studies represent a distribution of true
intervention effects. Considerable heterogeneity of effect sizes was expected given the
differences in interventions and samples across the included studies. As the Q statistic is
underpowered in cases of small sample size (Lipsey & Wilson, 2001), random effects
models were estimated regardless of the observed heterogeneity.
Results
Characteristics of Included Studies
Table 1 presents characteristics of the studies included in the analyses. Studies
included a wide range of intervention types, including therapy (n = 18), modified care (n
= 6), social support (n = 6), antidepressant medication (n = 2), educational programs (n =
2), dietary supplements (n = 2), and hormonal interventions (n = 1). Control group types
included treatment-as-usual (n = 24), educational programs (n = 7), placebo (n = 5), and a
nonspecific active treatment (n = 1). Interventions were initiated during pregnancy (n =
23), the first four weeks postpartum (n = 13), or during labor (n = 1). Prevention types
included indicated interventions (n = 3), selected/indicated interventions (n = 9), selected
interventions (n = 12), and universal interventions (n = 13). The timing of the postpartum
assessment ranged from 4 to 24 weeks, with the average assessment taking place at 14.6
weeks postpartum (SD = 6.7).
Characteristics of therapy interventions. Eighteen studies assessed therapeutic
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interventions. One study assessed training in guided relaxation provided via videotape;
this study was excluded from moderator analyses of therapy characteristics due to
differences in the method of administration of the intervention. The remaining studies
assessed cognitive-behavioral (n = 10), interpersonally-oriented (n = 5), and eclectic (n =
2) interventions. Studies included both group therapy (n = 10) and individuallyadministered therapy (n = 7). The average number of therapy sessions was 5.9 (SD = 3.0).
Methodological Quality
Table 2 presents characteristics of the included studies related to methodological
quality. Two studies were quasi-randomized trials; the remaining 35 studies were
randomized controlled trials. 62% of studies reported results on the basis of intent-to-treat
analyses. 95% of studies provided some information characterizing the included sample.
28% of studies excluded participants with current major depressive episodes. Of the 19
studies that included a clinician-administered measure, 63% reported that assessors were
blind to treatment status. Of the 35 randomized controlled trials, 83% specified the
method by which participants were randomized.
Methodological quality of therapy interventions. Eighteen studies included
therapeutic interventions. One of these interventions was provided via videotape. Of the
remaining 17 studies, 83% provided information about the therapists who provided the
intervention, 56% indicated that an intervention manual was utilized, 78% indicated that
therapists received training in the intervention, 67% indicated that therapists received
supervision during the study, and 44% assessed sessions for adherence to the
intervention.
Methodological quality of pharmacological interventions. Five studies
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included pharmacological interventions (antidepressant medication, dietary supplements,
or hormonal interventions). For these studies, 80% reported that clinicians were blind to
treatment status and 100% reported that participants were blind to treatment status.
Postpartum Depressive Symptoms
Table 3 presents the results of the random effects model for postpartum
depressive symptoms, representing results from 24 studies. These effect sizes represent
the difference between depressive symptoms at the postpartum assessment closest to 6
months postpartum; positive effect sizes indicate superiority of treatment to control
conditions. Effect sizes (Hedges’ g) ranged from -0.20 to 12.10; eight studies had
significant effect sizes, all in favor of the treated condition. There was a significant
overall effect of treatment (g = 0.37, 95% CI 0.15-0.60, p < 0.001). Two studies had
SAMD values greater than 2.58. Visual inspection of the scree plot of the rank-ordered
SAMD scores suggested that the SAMD values for the studies by Small and colleagues
(2000) and Wolman and colleagues (1993) were discrepant with the overall distribution
of SAMD scores. These studies were excluded from subsequent analyses; the average
effect size excluding these outliers was g = 0.18 (95% CI 0.09-0.27, p < 0.001).
We also used meta-analysis to assess the average level of depressive symptoms at
six months postpartum in treatment and control conditions. In the 14 studies that utilized
the EPDS as a measure of depressive symptoms, the average EPDS score was 7.06 in
treatment conditions, compared to 7.69 in control conditions. In the five studies that used
the BDI-II as a measure of depressive symptoms, the average BDI score was 8.99 in
treatment conditions, compared to 8.55 in control conditions. In the two studies that used
the CES-D as a measure of depressive symptoms, the average CES-D score was 1.49 in
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treatment conditions, compared to 1.57 in control conditions.
Results of tests for publication bias were acceptable. The fail-safe N value was
129, which exceeds the tolerance value of 120. While the funnel plot was slightly
asymmetric (see Figure 2); trim-and-fill procedures suggested no missing studies. The Q
statistic indicated that there was significant heterogeneity among effect sizes (p < 0.05).
The I2 value indicated a medium level of heterogeneity, with 37% of the variance in
effect sizes attributable to between-study variance (Higgins et al., 2003).
Moderator Analyses: Postpartum Depressive Symptoms
Because both the Q statistic and I2 index indicated significant heterogeneity of
effect sizes, exploratory analyses of potential moderators were conducted. Subgroups
including only one study were excluded from moderator analyses.
Study characteristics. Nine characteristics of the included studies were assessed
as potential moderators: intervention type (general, biological vs. psychosocial, and EST
vs. non-EST), control group type, timing of intervention, type of prevention, measure,
whether the study excluded women with a current major depressive episode, timing of
postpartum assessment, and average pre-treatment depressive symptoms (see Table 4).
No categorical variables were significant moderators of effect size. There was a trend for
later assessment timing was associated with smaller effect sizes; slope = -0.01, p = 0.05.
In studies that assessed depressive symptoms using the EPDS, higher levels of depressive
symptoms at pre-treatment were associated with smaller effect sizes, slope = -0.07, p <
0.01. There was no relationship between depressive symptoms at pre-treatment and effect
size in studies that assessed depressive symptoms using the BDI-II, slope = 0.01, p >
0.05.
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Intervention variables. Three characteristics of interventions for studies
assessing psychotherapeutic interventions were assessed as potential moderators:
therapeutic orientation, method of administration, and number of sessions. There were
not enough studies representing other types of interventions to assess moderators for
these interventions. No categorical characteristics of psychotherapeutic interventions
were significant moderators of effect size. There was a trend for studies with more
therapy sessions to have smaller effect sizes; slope = -0.04, p = 0.06.
Postpartum Depression Diagnosis
Table 5 presents the results of the random effects model for postpartum
depression diagnoses, representing results from 28 studies. Odds ratios for individual
studies ranged from 0.02 to 1.79. Odds ratios were significant for eight individual studies;
seven in favor of the treated condition and one in favor of the control condition. There
was a significant overall positive effect of treatment (OR = 0.72, 95% CI 0.0.56-0.94, p =
0.01), representing a 28% reduction in risk for postpartum depression in treatment groups
compared to control groups. Nine studies had SAMD values greater than 2.58. Visual
inspection of the scree plot of the rank-ordered SAMD scores indicated that the value for
the studies by Kozinszky and colleagues (2012) and Small and colleagues (2000) were
discrepant. These studies were excluded from subsequent analyses. The average effect
size, excluding these outliers, was OR = 0.67 (95% CI 0.52-0.85, p < 0.01), which
represents a 33% reduction in risk for treatment groups compared to control groups.
Results of tests for publication bias indicated potential bias in the included
studies. The fail-safe N value was 147, which exceeds the tolerance limit of 140. The
funnel plot was asymmetric (see Figure 3), and the trim-and-fill correction suggested 5
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studies missing to the right of the mean. After correction for publication bias, the overall
effect size was 0.73 (95% CI 0.56-0.95), which represents a 27% reduction in the risk for
treatment groups compared to control groups. The Q statistic indicated that there was
significant heterogeneity among the effect sizes (p < 0.01). The I2 value indicated a
medium level of heterogeneity, with 46% of the variance in effect sizes attributable to
between-study variance (Higgins et al., 2003).
Moderator Analyses: Postpartum Depression Diagnosis
Study characteristics. Ten characteristics of the included studies were assessed
as potential moderators: intervention type (general, biological vs. psychosocial, and EST
vs. non-EST), control group type, timing of intervention, type of prevention, method of
diagnosing depression, whether the study excluded women with a current major
depressive episode, timing of postpartum assessment, and baseline depressive symptoms
(see Table 6). No categorical variables were significant moderators of effect size. Studies
with later assessments had larger effect sizes, slope = 0.02, p < 0.05. There was no
relationship between depressive symptoms at pre-treatment and effect size in studies that
assessed depressive symptoms using the EPDS, slope = 0.04, p > 0.05.
Intervention variables. Three characteristics of interventions for studies
assessing psychotherapeutic interventions were assessed as potential moderators:
therapeutic orientation, method of administration, and number of sessions. There were
not enough studies representing other types of interventions to assess moderators for
these interventions. None of these variables was a significant moderator of effect size.
Discussion
Results of these meta-analyses suggest that a wide range of interventions may be
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effective in the prevention of depression during the first 6 months postpartum. These
interventions result in small but significant reductions in depressive symptoms (g = 0.18)
and the prevalence of depressive episodes (OR = 0.73). Although the magnitude of the
effects of preventive interventions are modest compared to treatments for postpartum
depression, which a previous meta-analysis found to be in the medium range (g = 0.65,
Sockol, Epperson, & Barber, 2011), the efficacy of these interventions is comparable to,
or exceeds, the efficacy of preventive interventions for anxiety and depression from other
meta-analyses (Cuijpers, van Straten, Andersson & van Oppen, 2008; Zalta, 2011). The
overall level of depressive symptoms at six months postpartum in both treatment and
control conditions were below generally accepted cutoffs for clinically significant
depressive symptoms (Cox, Chapman, Murray & Jones, 1996; Dozois & Dobson, 2002).
For both depressive symptoms and depression diagnosis, a later assessment was
associated with a smaller difference between intervention and control conditions. This is
consistent with the results of a meta-analysis of treatments for postpartum depression,
which found that treatment length was associated with smaller effect sizes (Sockol,
Epperson, & Barber, 2011). Moreover, it is consistent with evidence that postpartum
depression tends to naturally remit over time (Heron et al., 2004). Given that the natural
course of postpartum depression is for symptom severity to decrease over time, it is
unsurprising that preventive interventions appear to be most efficacious when they are
assessed early during the postpartum period. However, this should not be taken as an
indication that preventive interventions are unnecessary. Given the adverse impact of
depression on depressed women and their children, even a self-limiting depressive
episode may be extremely distressing and increase the risk for long-term negative
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outcomes.
Higher levels of depressive symptoms at pre-treatment were associated with
smaller differences in depressive symptoms at six months postpartum between treatment
and control conditions in studies that used the EPDS as a measure of depressive
symptoms. As this result was only found in one of our analyses, and for only one measure
of depressive symptoms, this result should be interpreted with caution. However, if this
finding represents a true difference in the efficacy of preventive interventions, this
suggests that preventive interventions might be more effective for women who are not yet
experiencing significant levels of depressive symptoms. The duration or intensity of
preventive interventions may not be sufficient to prevent the onset of depressive episodes
or worsening of symptoms among this population.
Interestingly, we found that intervention type was not related to the effectiveness
of treatments for either reducing depressive symptoms or preventing depressive episodes.
A lack of social support is an established risk factor for postpartum depression (Beck,
1996). It may be that nonspecific social contact and support is sufficient for reducing risk
for depression among this population and that the specific active elements of treatment
are less important. However, further research assessing the efficacy of less well-studied
interventions is necessary to determine whether our failure to identify moderators simply
results from a lack of sufficient evidence. Given the small number of studies representing
antidepressant medication and non-traditional interventions, particularly dietary
supplements and hormonal interventions, further research is necessary to establish
whether these approaches are truly equally efficacious.
One limitation of this meta-analysis was the use of uncontrolled effect sizes. This
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raises the concern that differences at post-treatment may actually reflect pre-existing
differences between treatment and control conditions. A separate meta-analysis was
conducted assessing the average change in depressive symptoms from pre-treatment to
post-treatment between treatment and control conditions using the standardized mean
gain score using the 13 studies for which this effect size could be calculated. The fail-safe
N for this analysis was 17, which is well below the tolerance value, so the results should
be interpreted with caution. With this caveat, this analysis also found a small but
significant difference in the reduction in depressive symptoms between treatment and
control conditions, Hedges’ g = 0.15, p = 0.01, 95% CI 0.03-0.27. The results of this
analysis suggest that our findings are unlikely to simply reflect pre-existing differences
between treatment and control conditions.
While the number of studies included in these meta-analyses is comparable to
other meta-analyses of preventive interventions (e.g., Cuijpers et al., 2008; Zalta, 2011),
moderator analyses assessed small subgroups of studies. Because of this, moderator
analyses should be interpreted with caution. This is particularly true for the analyses of
intervention type. There were relatively few studies assessing antidepressant medication,
dietary supplements, educational interventions, hormonal interventions, and social
support programs. More research assessing the efficacy of these interventions is
necessary in order to establish whether there are systematic differences between types of
interventions. Similarly, psychotherapy was the only type of intervention for which
enough studies were present to assess for potential moderation of specific aspects of the
intervention. Further evaluation of other types of interventions would allow for similar
questions to be asked of these interventions; for example, whether phone-based social
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support programs have comparable efficacy to in-person support groups.
A major concern raised by these analyses is the evidence that published studies
are biased in favor of studies with significant positive findings. While the overall effect
for preventive interventions remained significant even after correction for publication
bias, there is no statistical approach that can take the place of real data for moderator
analyses. While our analyses found no evidence that types of interventions or
characteristics of interventions were associated with efficacy, it is possible that there are
systematic characteristics of ineffective interventions that we were unable to assess
because these results have not been published. This may have limited our ability to
identify moderators of effect size. While the “file-drawer problem” is well-known, these
analyses provide further evidence that null findings from well-designed prevention
studies are vitally important to a full understanding of these interventions.
In summary, these analyses suggest that a wide range of interventions are
effective in the prevention of postpartum depression. At six months postpartum, these
interventions are associated with a 27% reduction in the prevalence of depressive
episodes and a reduction in levels of depressive symptoms compared to control
conditions. Effect sizes were larger in studies that assessed depression earlier in the
postpartum period; this is consistent with natural remission of depressive symptoms over
the course of the postpartum period. There were no differences between types of
interventions, and different types of psychotherapeutic interventions appeared to have
comparable efficacy. There were few studies assessing antidepressant medication and
other non-therapeutic interventions; more research is necessary to assess whether these
interventions are effective and to establish whether characteristics of other intervention
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types are related to efficacy. Although more research is needed to confirm and extend the
results of these meta-analyses, these results suggest that a wide range of interventions
should be targeted for further investigation as preventive interventions for this disorder.
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-

+

-

N/A

+

Ngai, Chan, & Ip (2009)

+

+

-

N/A

Rees (1995)

+

+

-

Shields & Reid (1997)

-

+

Silverstein et al. (2011)

+

Small et al. (2000)

+

Study

+

+

+

+

+

-

+

+

Pharmacological
Blind
Clin
Blind Pt

+

+

-

+

+

+

+

+

+

+

+

+

+

QR

+

-

+

-

-

N/A

-

N/A

N/A

N/A

N/A

N/A

-

N/A

-

+

-

+

+

+

+

+

+

+

+

-

N/A

+

149
Therapy
ITT

Excl Curr
MDE

Blind
Assess

Spec
Random

Stamp, Williams, & Crowther (1995)

+

+

-

N/A

+

Webster et al. (2003)

+

+

-

N/A

+

Wisner et al. (2001)

+

-

+

+

+

+

+

Wisner et al. (2004)

+

+

+

+

+

+

+

Wolman et al. (1993)

-

+

-

+

+

Zayas, McKee, & Jankowski (2004)

-

+

-

N/A

-

+

-

+

+

-

Zlotnick, Capezza, & Power (2011)

+

+

+

-

+

+

+

+

+

-

Zlotnick et al. (2001)

-

+

+

-

-

-

-

-

-

-

Study

Spec
Ther

Pharmacological
Blind
Clin
Blind Pt

Char
Sample

Manual

Training

Super

Adher

Zlotnick et al. (2006)
+
+
+
+
+
+
Note. ITT = report intent-to-treat analyses, Char Sample = specify characteristics of sample, Excl Curr MDE = assess for depressive episode pre-treatment and exclude subjects who meet diagnostic
criteria, Blind Assess = clinician-administered diagnostic measures conducted by independent evaluator blind to treatment condition, Spec Random = specification of method of randomization, Spec
Ther = specify therapist characteristics, Manual = specify use of therapy manual, Training = describe therapist training, Super = describe therapist supervision, Adher = indicate therapy was assessed for
adherence to manual, Blind Clin = clinician blind to treatment status, Blind Pt = patient blind to treatment status, + = Yes, - = No, N/A = Not Applicable, QR = Quasi-Randomized
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Table 3
Random Weighted Effect Sizes (Hedges’ g) Comparing Depressive Symptoms
Between Treatment and Control Conditions at 6 Months Postpartum
Study
Armstrong et al. (1999)
Chabrol et al. (2002)
Dennis et al. (2009)
Gao, Chan, & Sun (2012)
Gorman (1997)
Gunn et al. (1998)
Hayes, Muller, & Bradley (2001)
Ho et al. (2009)
Lawrie et al. (1998)
Le, Perry, & Stuart (2011)
Llorente et al. (2003)
Logsdon et al. (2003)
Marks, Siddle, & Warwick (2003)
Mokhber et al. (2011)
Munoz et al. (2007)
Ngai, Chan, & Ip (2009)
Rees (1995)
Shields & Reed (1997)
Small et al. (2000) 1
Wolman et al. (1993) 1
Zayas, McKee, & Jankowski (2004)
Zlotnick, Capezza, & Parker (2011)
Zlotnick et al. (2001)
Zlotnick et al. (2006)
Total (all studies)
Total (outliers excluded)
* p < 0.05, ** p < 0.01, *** p < 0.001
1
Outlier excluded from subsequent analyses.

n
181
211
600
194
30
475
188
168
168
174
89
109
85
85
41
184
60
788
917
149
57
35
86
54
k
24
22

Hedges’ g
0.44**
0.42**
0.13
0.34*
0.02
0.02
0.1
0.39*
-0.12
-0.09
-0.15
-0.2
0
0.39
0.24
0.42**
0.61*
0.18**
-0.08
12.10***
0.07
0.32
0.44
0.09
Hedges’ g
0.37***
0.18***

95% CI
0.14-0.73
0.15-0.70
-0.03-0.29
0.06-0.62
-0.68-0.72
-0.16-0.20
-0.18-0.39
0.09-0.70
-0.42-0.19
-0.38-0.21
-0.56-0.26
-0.65-0.25
-0.42-0.42
-0.03-0.82
-0.36-0.84
0.13-0.71
0.10-1.12
0.04-0.32
-0.21-0.05
10.69-13.51
-0.44-0.59
-0.21-0.85
-0.22-1.10
-0.33-0.51
95% CI
0.15-0.60
0.09-0.27

SAMD
1.97
2.05
-0.17
1.39
-0.33
-1.38
-0.27
1.61
-1.67
-1.52
-1.38
-1.76
-0.65
1.15
0.30
1.89
1.78
0.60
-3.55
70.69
-0.25
0.86
-0.22
0.64
Q(df)
321.40(23)***
33.32(21)*

I2
92.84
36.98
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Table 4
Analyses of Moderation for Depressive Symptoms at 6 Months Postpartum
Moderator
Intervention Type
Dietary Supplement
Educational
Modified Care
Therapy
Social Support
Intervention Type
Biological
Psychosocial
Intervention Type
EST
Non-EST
Control Group Type
Educational
Placebo
TAU
Intervention Timing
Pregnancy
Postpartum
Type of Prevention
Indicated
Selected
Selected/Indicated
Universal
Measure
BDI-II
CES-D
EPDS
Exclude Current MDE
No
Yes
Psychotherapy Orientation
CBT
IPT
Method of Psychotherapy
Administration
Group
Individual
†

p < 0.10,* p < 0.05, ** p < 0.01, *** p < 0.001

N

Hedges’ g

95% CI

2
2
4
11
2

0.12
0.24
0.16
0.27***
0.04

-0.42-0.65
-0.04-0.53
-0.01-0.33
0.14-0.40
-0.25-0.33

3
19

0.02
0.20***

-0.30-0.35
0.11-0.29

10
12

0.25***
0.14*
0.38***
0.02
0.16***

0.18-0.58
-0.30-0.35
0.07-0.25

14
8

0.18***
0.20*

0.09-0.26
0.03-0.36

3
4
5
10

0.22*
0.18
0.03
0.19**

0.01-0.44
-0.10-0.47
-0.11-0.23
0.07-0.32

5
2
13

0.00
0.20
0.23***

-0.19-0.18
-0.60-.99
0.12-0.34

15
7

0.19***
0.13

0.08-0.29
-0.02-0.29

6
4

0.23
0.27**

0.23*
0.31**

p
0.60

1.06(1)

0.30

1.56(1)

0.21

4.89(2)

0.09

0.06(1)

0.81

2.17(3)

0.54

4.34(2)

0.11

0.32(1)

0.58

0.06(1)

0.80

0.39(1)

0.53

0.12-0.38
0.03-0.25

2
3
16

5
5

Q(df)
2.73(4)

0.00-0.46
0.07-0.47

0.04-0.41
0.11-0.52
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Table 5
Random Weighted Effect Sizes (Odds Ratio) Comparing Prevalence of Depressive
Episodes Between Treatment and Control Conditions at 6 Months Postpartum
Study
Armstrong et al. (1999)
Austin et al. (2008)
Brugha et al. (2000)
Chabrol et al. (2002)
Dennis et al. (2009)
Elliott et al. (2000)
Gorman (1997)
Gunn et al. (1998)
Hagan, Evans, & Pope (2004)
Kozinszky et al. (2012) 1
Lara, Navarro, & Navarrete (2010)
Lawrie et al. (1998)
Le, Perry, & Stuart (2011)
Marks, Siddle, & Warwick (2003)
Milgrom et al. (2011)
Munoz et al. (2007)
Nalepka & Coblentz (1995)
Shields & Reid (1997)
Silverstein et al. (2011)
Small et al. (2000) 1
Stamp, Williams, & Crowther (1995)
Webster et al. (2003)
Wisner et al. (2001)
Wisner et al. (2004)
Wolman et al. (1993)
Zlotnick, Capezza, & Parker (2011)
Zlotnick et al. (2001)
Zlotnick et al. (2006)
Total (all studies)
Total (outliers excluded)
Total (trim-and-fill correction)
* p < 0.05, ** p < 0.01, *** p < 0.001
1
Outlier excluded from subsequent analyses.

n
181
277
190
211
600
99
37
475
192
1719
116
168
174
87
89
41
72
788
42
917
121
369
51
22
149
35
86
54
k
28
26

OR
0.24
0.94
0.49
0.46
0.80
0.38
0.57
1.26
1.02
1.79
0.36
1.13
1.38
1.05
0.24
0.17
0.94
0.66
0.40
1.26
1.62
0.80
0.95
0.08
0.02
1.68
0.06
0.17
OR
0.72*
0.67**
0.73*

95% CI
0.09-0.65
0.50-1.76
0.12-2.02
0.26-0.81
0.49-1.31
0.15-0.94
0.11-3.03
0.76-2.09
0.47-2.23
1.30-2.48
0.13-1.01
0.59-2.18
0.52-3.67
0.41-2.73
0.08-0.69
0.01-3.82
0.18-4.98
0.47-0.94
0.11-1.51
0.88-1.80
0.54-4.89
0.50-1.28
0.26-3.45
0.01-0.90
0.00-0.40
0.36-7.86
0.00-1.08
0.03-0.88
95% CI
0.56-0.94
0.52-0.85
0.56-0.95

SAMD
-3.30
1.79
-1.54
-1.95
1.00
-1.73
-0.43
5.63
2.04
18.00
-1.95
2.60
4.18
1.51
-2.31
-1.68
0.88
-0.70
-1.01
7.39
4.79
0.81
0.77
-1.44
-4.17
2.68
-3.00
-2.01
Q(df)
74.83(27)***
45.95(25)**
61.93

I2
63.92
45.60
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Table 6
Analyses of Moderation for Depressive Episodes at 6 Months Postpartum
Moderator
Intervention Type
Medication
Modified Care
Therapy
Social Support
Intervention Type
Biological
Psychosocial
Intervention Type
EST
Non-EST
Control Group Type
Educational
Placebo
TAU
Intervention Timing
Pregnancy
Postpartum
Type of Prevention
Indicated
Selected
Selected/Indicated
Universal
Criterion for Diagnosis
Clinical
Cutoff
Exclude Current MDE
No
Yes
Psychotherapy Orientation
CBT
IPT
Method of Psychotherapy
Administration
Group
Individual
†

p < 0.10,* p < 0.05, ** p < 0.01, *** p < 0.001

n

OR

95% CI

2
5
13
4

0.34
0.61
0.57**
0.77

0.03-3.85
0.31-1.19
0.38-0.84
0.46-1.31

3
23

0.71
0.61**

0.24-2.12
0.50-0.84

14
12

0.58**
0.73*

0.39-0.87
0.54-1.00

4
3
19

0.82
0.71
0.62**

0.53-1.25
0.24-2.12
0.46-0.83

16
9

0.70
0.67**

0.47-1.05
0.50-0.90

2
10
9
5

0.62
0.60*
0.60*
0.84

0.36-1.07
0.38-0.97
0.36-0.99
0.48-1.46

12
14

0.64*
0.67*

0.42-0.99
0.50-0.92

17
9

0.68**
0.56

0.53-0.89
0.29-1.10

8
4

0.63*
0.40

0.41-0.97
0.11-1.51

8
5

0.62
0.46**

0.36-1.07
0.29-0.73

Q(df)
1.13(3)

p
0.77

0.02(1)

0.88

0.82(1)

0.37

1.13(2)

0.57

0.03(1)

0.87

1.05(3)

0.79

0.03(1)

0.87

0.27(1)

0.60

0.41(1)

0.52

0.71(1)

0.40

Included

Eligibility

Screening

Identification
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Records identified through
database searching & reference
review
(n = 919)

Records after duplicates removed
(n = 797)

Full-text articles assessed for
eligibility
(n = 118)

Studies
included in
meta-analysis
(depression
symptoms)
n = 24
(n = 14)

Full-text articles excluded:
Target Outcome (n = 17)
Study Design (n = 16)
Insufficient Outcome Data
(n = 14)
Secondary Manuscript (n = 12)
Timing of Intervention (n = 11)
Timing of Assessment (n = 5)
Treatment Study (n = 4)
Outcome Measure (n = 1)

Studies
included in
meta-analysis
(depression
diagnosis)
n = 28
(n = 25)

Figure 1. Flow chart illustrating identification of included studies.
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Funnel Plot of Standard Error by Hedges's g
0.0

Standard Error

0.1

0.2

0.3

0.4
-2.0

-1.5

-1.0

-0.5

0.0

0.5

1.0

1.5

2.0

Hedges's g

Figure 2. Funnel plot for studies assessing the difference between depressive symptoms
between treatment and control conditions at 6 months postpartum. The asymmetric
distribution of studies in the lower half of the funnel plot suggests that there are missing
studies with negative effect sizes, in which control conditions would be superior to
treatment conditions.
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Funnel Plot of Standard Error by Log odds ratio
0.0

Standard Error

0.5

1.0

1.5

2.0

-4

-3

-2

-1

0

1

2

3

4

Log odds ratio

Figure 3. Funnel plot for studies assessing the difference in prevalence of depressive
episodes between treatment and control conditions at 6 months postpartum. The
asymmetric distribution of studies in the lower half of the funnel plot suggests that there
are missing studies with odds ratios greater than 0, in which control conditions would be
superior to treatment conditions.
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General Discussion
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Overall, the results of the studies included in this dissertation contribute to our
understanding of perinatal mood and anxiety disorders. These studies build on previous
research on risk factors and interventions for these disorders. The results of these studies
provide important guidance for clinicians and researchers with interests in perinatal
mental health.
The studies included in Chapter 1 help further our understanding of an important
risk factor for perinatal depression and anxiety: maternal attitudes. Beck’s cognitive
model (1967, 1976, 1985) suggests that negative maternal attitudes could function as a
specific vulnerability to perinatal depression and anxiety. Previous research into the role
of maternal attitudes in the development of perinatal depression and anxiety had been
limited by the need for a measure of maternal attitudes that was not confounded with
women’s expectations or experiences of motherhood and by the limited validity and
reliability of existing measures, particularly among first-time mothers (Sockol, 2008). We
demonstrated that our measure, the Attitudes Toward Motherhood scale (AToM), is
reliable and has good convergent validity with general cognitive biases and an existing
measure of maternal attitudes. This measure provides researchers and clinicians with an
important tool for the assessment of this construct.
Development of the Attitudes Toward Motherhood scale enabled us to then use
this measure to assess the relationship between maternal attitudes and symptoms of
depression and anxiety among first-time pregnant and postpartum mothers. We found that
dysfunctional maternal attitudes were strongly predictive of symptoms of depression and
anxiety. This was true even after controlling for general cognitive biases, which suggests
that maternal attitudes contribute uniquely to risk for perinatal distress above and beyond
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general cognitive style. Furthermore, both dysfunctional maternal attitudes and general
cognitive biases predicted symptoms of depression and anxiety after controlling for
marital satisfaction and social support, which are known robust risk factors for these
symptoms. Interpersonal risk factors also continued to predict symptoms of depression
and anxiety when cognitive risk factors were controlled for, which suggests that both
cognitive and interpersonal risk factors play an important role in the development of
symptoms of depression and anxiety.
While the results of the studies included in Chapter 1 have interesting
implications for clinicians and researchers interested in developing interventions for
perinatal depression and anxiety, these findings are too preliminary to directly lead to
changes in our approach to interventions for these disorders. The overarching goals for
the studies included in Chapters 2 and 3 was to synthesize research that has already been
conducted on treating and preventing postpartum depression in order to assess the overall
efficacy of interventions that have been subjected to scientific study and to examine
whether there might be characteristics of studies or interventions that are systematically
associated with differences in efficacy.
The results of the meta-analyses included in Chapter 2 provide strong evidence
for the efficacy of psychotherapy and antidepressant medications in the treatment of
perinatal depression. These analyses demonstrate that these interventions are associated
with significant decreases in depressive symptoms over time and that interventions lead
to significantly greater reductions in depressive symptoms as compared to control
conditions. Perhaps the most interesting finding from this study is that interpersonal
psychotherapy was more effective than cognitive-behavioral therapy. This is somewhat
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surprising, as the results of the studies included in Chapter 1 suggest that both
interpersonal and cognitive risk factors are strongly associated with symptoms of
depression – thus we might expect that interventions targeting either interpersonal or
cognitive factors might be equally efficacious. One possible explanation for this finding
is that there were notable methodological differences between studies assessing
interpersonal psychotherapy compared to cognitive-behavioral therapy. The ambiguity of
this finding highlights the need for further research in this area, and particularly suggests
that a head-to-head comparison of interpersonal psychotherapy and cognitive-behavioral
therapy in a methodologically rigorous trial would be an important contribution to
research in this area.
The results of the meta-analyses included in Chapter 3 provide evidence that
preventive interventions for postpartum depression result in significant reductions in
depressive symptoms and the prevalence of depressive episodes, although the magnitude
of effect is smaller than found for treatment studies in Chapter 2. At six months
postpartum, subjects in treated conditions had significantly lower levels of depressive
symptoms than subjects in control conditions. Subjects were also 27% less likely to
experience a depressive episode during the first six months postpartum when they
received an intervention. Interestingly, we did not find differences among the different
types of interventions, and there was no difference in the efficacy of cognitive-behavioral
therapy and interpersonal psychotherapy. This provides additional evidence that this
result in Chapter 2 may reflect methodological differences between the included studies,
rather than a true difference between these types of psychotherapy.
Limitations and Future Directions
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The studies included in this dissertation represent promising first steps toward a
more full understanding of these disorders. Further research is necessary to build upon
the results of these studies and to help answer the questions that they raise.
One of the major limitations of Chapter 1 was the cross-sectional design of the
included studies. While the results of these studies are consistent with a diathesis-stress
model of depression and anxiety, a longitudinal design is necessary to assess whether
dysfunctional maternal attitudes are truly a risk factor for symptoms of depression and
anxiety, or whether these attitudes may simply be a reflection of the symptoms
themselves. We are currently conducting a follow-up study to assess whether
dysfunctional maternal attitudes during pregnancy are predictive of symptoms of
depression and anxiety at 12 weeks postpartum.
Another limitation of the studies included in Chapter 1 was that we limited our
sample to women who were pregnant with, or had recently given birth to, their first child.
We decided to limit our sample due to differences that we had observed in the
relationships among cognitive biases, maternal attitudes, and depressive symptoms
between primiparous and multiparous subjects in our previous research (Sockol, 2008).
As a previously utilized measure of maternal attitudes had proven particularly
problematic for first-time mothers, we wanted to ensure that our measure was reliable and
valid among this population. Replication of the results of this study with a sample of
multiparous subjects is necessary to demonstrate that this measure is reliable and valid
among all childbearing women.
As for all meta-analyses, the studies included in Chapters 2 and 3 are limited by
the availability and quality of research studies assessing the efficacy of treatments and
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preventive interventions for perinatal depression. While the absolute number of studies
included in these meta-analyses was comparable to that of similar meta-analyses, certain
sub-groups of interventions were represented by small numbers of studies. Results
regarding interventions represented by small numbers of studies should be interpreted
with caution. For example, in Chapter 2, we identified only four studies of antidepressant
medication. Three of these studies were open trials, and none of these studies assessed the
efficacy of antidepressants among depressed pregnant women. This was also true in
Chapter 3, in which we only identified two randomized controlled trials of antidepressant
medication for the prevention of postpartum depression, both of which were initiated in
the immediate postpartum period. Clinicians are sometimes reluctant to prescribe
antidepressant medication for women who are pregnant or breastfeeding and there is
evidence that the use of selective serotonin reuptake inhibitors during pregnancy is
associated with increased risk for congenital malformations (Alwan, Reefhuis,
Rasmussen, Olney, & Friedman, 2007; Bar-Oz et al., 2007; Wurst, Poole, Ephross, &
Olshan, 2010). However, there is also evidence for an increased risk of relapse among
women who discontinue antidepressant treatment during pregnancy (Cohen et al., 2006).
In order for clinicians and patients to make fully informed decisions about the risks and
benefits of treatment, further research assessing the efficacy of antidepressant
medications among this population – particularly in comparison to psychotherapeutic
treatments, which may have lower risks or be more acceptable to patients – is necessary.
Perhaps more worrisome than the limited number of studies included in these
meta-analyses, particularly for non-psychotherapeutic interventions, is evidence of
publication bias in both treatment and prevention studies. In most of our analyses,
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examination of funnel plots and Duval and Tweedie’s (2000) trim-and-fill procedure
suggested that we were missing studies with non-significant findings. For our main
analyses, we were able to utilize statistical corrections that can estimate the overall effect
size if these missing studies were included. However, this is not possible for moderator
analyses. It is possible that there are systematic differences among studies that are
published versus unpublished that might bias the findings of our meta-analyses. For
example, consider our finding in Chapter 3 that there is no significant difference in the
prevalence of postpartum depressive episodes at 6 months postpartum between the
different types of interventions. This finding is based on 13 studies of psychotherapeutic
interventions, 5 studies of modified medical care, 4 studies of social support, and 2
studies of antidepressant medication. If several unpublished studies represent randomized
controlled trials of social support interventions that failed to find that they reduced the
prevalence of postpartum depression during the postpartum period, we would expect to
find a difference among intervention types if we were able to include these missing
studies in our moderator analyses. Thus the evidence of publication bias found in these
meta-analyses limits our confidence in our findings, particularly for moderator analyses.
The inclusion criteria we followed in the two meta-analyses have their own
limitations. In Chapter 2, we decided to limit the included interventions to
psychotherapeutic interventions and antidepressant medications. Because effective
treatments for depression in adult populations have been identified (Cuijpers, van Straten,
Andersson, & van Oppen, 2008; Joffe, Sokolov & Streiner, 1996), our goal for this metaanalysis was to assess the efficacy of established interventions among perinatal
populations. As a result, we did not include other potential interventions, such as dietary
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supplements or hormonal interventions. This allowed us to make more rigorous
comparisons between treatments, but there is a risk that effective and acceptable
treatments may have been excluded from our analyses. In Chapter 3, in contrast, we
decided to include a much wider range of potential interventions. The strength of this
approach is that we were able to identify a wide range of interventions that appear to be
effective in reducing depressive symptoms and the prevalence of depressive episodes
during the postpartum period. As women may be more receptive to complementary and
alternative approaches to treatment, particularly during pregnancy, it is important for
research to assess whether these approaches are efficacious (Battle, Uebelacker, Howard,
& Castaneda, 2010). However, given the wide variations in intervention types, it was
difficult to conduct direct comparisons of all of the interventions included in these
analyses.
Conclusions
The cumulative results of these studies provide a hopeful message to clinicians,
researchers, and mothers. In Chapter 1, we found that dysfunctional maternal attitudes,
general cognitive biases, and interpersonal risk factors each have incremental predictive
validity for symptoms of depression and anxiety. This provides evidence that emotional
distress in this population is multi-factorial, and thus may be responsive to a wide range
of approaches to intervention and prevention. The results of the meta-analyses in
Chapters 2 and 3 provide further empirical support for this. Several types of
antidepressant medications and psychotherapies were effective in the treatment of
perinatal depression, and an even wider range of preventive interventions were found to
effectively reduce depressive symptoms and the prevalence of depressive episodes during
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the postpartum. The efficacy of such a wide range of interventions provides opportunities
for selecting interventions that correspond with patients’ preferences and access to care.
While women often express a preference for psychotherapeutic interventions during this
time period, there are also practical barriers to access to care that may lead some women
to prefer pharmacologic or other interventions (Kim et al., 2011).
A more thorough understanding of the mechanisms that underlie the development
of depression and anxiety during the perinatal period, and application of this
understanding to the development of interventions to treat and prevent these disorders, is
vitally important. These disorders are common and negatively affect not only the women
who suffer from their symptoms, but also their developing children. While the context of
pregnancy and the early postpartum period may confer additional risks, it also provides
clinicians and researchers with opportunities – this is a time of increased access to and
utilization of healthcare, and women may be particularly motivated to seek treatment by
their desire to provide a healthy environment for their developing children. The studies
included in this dissertation represent important steps toward an understanding of these
disorders that can be used to help women achieve a healthy psychological adjustment
during the transition to parenthood.
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